diclofenac has been researched along with aceclofenac in 287 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (1.05) | 18.7374 |
| 1990's | 37 (12.89) | 18.2507 |
| 2000's | 87 (30.31) | 29.6817 |
| 2010's | 138 (48.08) | 24.3611 |
| 2020's | 22 (7.67) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Anan, I; Begum, A; Brännström, K; Gharibyan, AL; Iakovleva, I; Nilsson, L; Olofsson, A; Sauer-Eriksson, AE; Walfridsson, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carrasco, E; Felipe, A; Grau, M; Guasch, J; Juliá, S; Montero, JL | 2 |
| Movilia, PG | 1 |
| Yscla, A | 1 |
| Fernandez, MF; Guirao, I; Izquierdo, E; Rimbau, V; Torralba, A | 1 |
| Alfonso Moreno, V; Roig Catalá, E; Zaragoza Marcet, A | 1 |
| Hernández Beriain, J; Segura García, C | 1 |
| Antón Badiola, I; Ferreiro Seoane, JL; Formigo Rodríguez, E; Gómez Rodríguez, N | 1 |
| de la Cruz, C; de Nicoläs, R; Egido, J; González, E; Herrero-Beaumont, G | 1 |
| Pallarés Querol, M | 1 |
| Ferreiro Seoane, JL; Formigo Rodríguez, E; Gómez Rodríguez, N; Moratiel Valdés, D | 1 |
| Boada, L; Epelde, F | 1 |
| Ansoleaga, JJ; Gijón-Baños, J; Martín-Mola, E | 1 |
| Bowdler, JM; Roma, J; Veys, EM; Ward, DE | 1 |
| Carmona, L; Díaz-González, F; García-Vicuña, R; González-Alvaro, I; González-Amaro, R; Laffón, A; Mollinedo, F; Sánchez-Madrid, F | 1 |
| Arañó, A; Basi, N; Duque, A; Gropper, S; Zapatero, MI | 1 |
| Bowdler, J; Kornasoff, D; Maisenbacher, J; Raber, A | 1 |
| Brogden, RN; Wiseman, LR | 1 |
| de Buergo, M; Montull Fruitós, E; Rico Lenza, H; Villa Alcázar, LF | 1 |
| Batlle-Gualda, E; Figueroa, M; Ivorra, J; Raber, A | 1 |
| Ferrer, F; Marcolongo, R; Parnham, MJ; Pasero, G; Serni, U | 1 |
| Balaguer, XG; Hunter, JA; Parnham, MJ | 1 |
| Bort, R; Carrasco, E; Castell, JV; Gómez-Lechón, MJ; Ponsoda, X | 2 |
| Alonso-Ruiz, A; Ansoleaga, JJ; Perez-Ruiz, F | 1 |
| Fernández González, MA; Fernández Ruiz, A; Pérez Moreno, JM; Puertas Montenegro, M | 1 |
| Alepuz Pou, M; Bermudez, A; Calero, E; Caliz, R; Cano, M; Caracuel, MA; Castellon Arce, P; Ffernandez Crisostomos, C; Garcia Lopez, A; Garcia Perez, S; Garcia Villalba, F; Garcia, C; Gines Martinez, F; Gonzalez, A; Gonzalez, J; Guzman Ubeda, M; Linares, LF; Lopez, MA; Marenco de la Fuente, IL; Mesa, J; Peréz Busquier, M; Povedano, A; Rodríguez, M; Roldan, R; Valenzuela, A | 1 |
| Bowdler, J; Frerick, H; Kornasoff, D; Montull, E | 1 |
| Capella, D; Figueras, A; Laporte, JR; Morros, R | 1 |
| Prieto de Paula, JM; Romero Castro, R; Villamandos Nicás, YV | 1 |
| Conti, M | 1 |
| Hashimoto, S; Kaneda, N; Kawai, S; Koshino, T; Matsuzaki, T; Mizushima, Y; Okamoto, R; Yamazaki, R; Yokokura, T | 1 |
| Gijón Baños, J | 1 |
| Gambaro, V; Saligari, E; Volpi, E | 1 |
| Frame, J; Hawkesford, JE; Marsden, J; Matthew, IR; Negus, TW; Seymour, RA | 1 |
| Scheen, AJ | 1 |
| Hashimoto, S; Kawai, S; Koshino, T; Matsumoto, T; Matsuzaki, T; Mizushima, Y; Okamoto, R; Yamazaki, R; Yokokura, T | 1 |
| Llenas, J | 1 |
| El Kousy, NM | 1 |
| Hashimoto, S; Ito, A; Kawai, S; Matsuzaki, T; Mizushima, Y; Yamazaki, R; Yokokura, T | 1 |
| Buchinger, W; Nadler, K; Pongratz, R; Rainer, F; Semlitsch, G | 1 |
| Choi, SJ; Jeong, CK; Kim, SB; Ko, GI; Lee, HS; Lee, MH; Sohn, DH | 1 |
| Blot, L; Devogelaer, JP; Manicourt, DH; Marcelis, A | 1 |
| Deby, CM; Deby-Dupont, GP; Henrotin, YE; Lamy, MM; Mouithys-Mickalad, AM; Reginster, JY; Zheng, SX | 1 |
| Carrasco, E; Castell, JV; Fabra, R; Gómez-Lechón, MJ; Pareja, E; Ponsoda, X; Trullenque, R | 1 |
| Kim, HJ; Kim, WB; Kim, YG; Kwon, JW; Lee, MG; Lee, SD; Lee, YJ; Shim, CK | 1 |
| Clements, S; Cox, M; Harrall, RL; Hazleman, BL; Riley, GP | 1 |
| Dooley, M; Dunn, CJ; Spencer, CM | 1 |
| Henrotin, Y; Paul, I; Reginster, JY | 1 |
| Badia, X; Brosa, M; Martínez, E; Peris, F | 1 |
| del Pozo, J; Fonseca, E; García Alvarez-Eire, GM; Goday Buján, JJ; Martinez, W | 1 |
| de Leval, X; Deby-Dupont, G; Delarge, J; Dogné, JM; Henrotin, Y; Mathy-Hartet, M; Mouithys-Mickalad, A; Reginster, JY | 1 |
| Chen, XJ; Liu, XQ; Peng, JH; Zhao, LH | 1 |
| El Kousy, NM; El-Moghazy Aly, SM; Mohammad, MA; Zawilla, NH | 1 |
| Blanco, FJ; Fernández-Sueiro, JL; Galdo, F; Lema, B; López-Armada, MJ; Maneiro, E | 1 |
| Fernández-Avala Novo, M; González Macías, J; Nan Nan, DN; Penado Nadela, S | 1 |
| Aslanidis, S; De Bast, J; Leeb, B; Lemmel, EM | 1 |
| el-Khateeb, SZ; el-Saharty, YS; Refaat, M | 1 |
| Kim, KM; Kim, YI; Yang, JH | 1 |
| Abdel-Elkawy, M; Elzeany, BE; Hasan, NY; Wagieh, NE | 1 |
| Brinkmeier, T; Frosch, PJ; Ludwig, C | 1 |
| Milachowski, KA; Schattenkirchner, M | 1 |
| Auge, D; Brune, K; Hinz, B; Rau, T; Rietbrock, S; Werner, U | 1 |
| Belenguer Varea, A; Cuesta Romero, C; Mallent Añón, J; Palop Larrea, V | 1 |
| Auge, D; Brune, K; Hinz, B; Ramer, R; Rau, T; Rietbrock, S; Werner, U | 1 |
| Admour, I; Alam, SM; Bader, M; Beshtawi, M; Dham, R; Idkaidek, N; Najib, N; Zaman, Q | 1 |
| Legrand, E | 1 |
| Acuña, JA; Sánchez-Batanero, P; Tascón, ML; Vázquez, MD | 1 |
| Castell, JV; Donato, MT; Gómez-Lechón, MJ; Perez-Cataldo, G; Ponsoda, X | 1 |
| Szilágyi, L | 1 |
| Chen, H; Gu, S; Jin, Y; Zeng, F | 1 |
| Carru, C; Deiana, L; Enrico, P; Porqueddu, E; Sotgia, S; Zinellu, A | 1 |
| Nasonova, VA | 1 |
| Fernández-Herrera, J; Fraga, J; García-Díez, A; Kutzner, H; Palmedo, G; Pascual, M; Requena, L; Yus, ES | 1 |
| Choi, HG; Gil, YS; Kim, CK; Kim, JO; Lee, KH; Oh, YK; Park, SM; Park, YJ; Rhee, JD; Woo, JS; Yong, CS; Yoo, BK; Yu, CH | 1 |
| Choi, YW; Kim, J; Lee, J; Lee, Y; Yoon, M | 1 |
| Fontanella, V; Presser Lima, PV | 1 |
| Alvarez-Soria, MA; Calvo, E; Egido, J; Hernández, M; Herrero-Beaumont, G; Largo, R; Sánchez-Pernaute, O; Santillana, J | 1 |
| Colás, C; Ferrer, L; Garcés, MM; Lezaun, A; Rojas-Hijazo, B | 1 |
| Dashora, K; Saraf, S | 1 |
| Fortea, J; Lamarca, R; Letzel, H; Mégard, Y; Raber, A | 1 |
| Chandanwale, AS; Jain, UK; Kapoor, S; Oak, J; Pareek, A | 1 |
| Arrue, I; Dominuez, JD; Vanaclocha, F; Vergara, A | 1 |
| Cheon, YK; Cho, YD; Han, CH; Jang, JY; Kim, BS; Kim, JH; Kim, YS; Kwon, KH; Moon, JH; Shim, CS; Song, HJ | 1 |
| Gide, PS; Jadhav, KR; Kadam, VJ; Pisal, SS; Shaikh, IM | 1 |
| de la Cuadra Oyanguren, J; García-Melgares Linares, ML; Pitarch Bort, G; Torrijos Aguilar, A | 1 |
| Castell, JV; Donato, MT; Gómez-Lechón, MJ | 1 |
| Aletras, AJ; Andonopoulos, AP; Giannopoulou, E; Gouvousis, PA; Panagiotopoulos, E; Syggelos, SA | 1 |
| de Kanter, R; Hewitt, NJ; LeCluyse, E | 1 |
| Anju, P; Manoj, K; Musmade, P; Mutalik, S; Naha, A; Prasanna, S; Ranjith, AK; Usha, AN | 1 |
| Musmade, P; Srinivasan, KK; Subramanian, G | 1 |
| Batlle-Gualda, E; Carbonell Abelló, J; Fortea Busquets, J; Linares Ferrando, LF; Martín-Mola, E; Raber Béjar, A; Román Ivorra, J; Tornero Molina, J | 1 |
| Arenas, L; Gavilan, MJ; Linares, T; Marcos, C | 1 |
| Dahiya, S; Pathak, K | 1 |
| Muatlik, S; Pandey, S; Ranjith, AK; Reddy, MS; Usha, AN | 1 |
| Díaz, Y; Fuentes, A; Izzo, C; Padrón, L; Rivas, C; Vargas, F; Zoltan, T | 1 |
| Müller, JB | 1 |
| Anju, P; Manoj, K; Mutalik, S; Usha, AN | 1 |
| Kang, W; Kim, EY | 1 |
| Hernandez-Vaquero, D; Sandoval, MA | 1 |
| Ahuja, A; Ali, J; Aqil, M; Baboota, S; Shafiq, S; Shakeel, F | 1 |
| Chotai, NP; Desai, JU; Gandhi, TR; Nagda, CD; Soni, TG | 1 |
| El Shamy, AA; Mansour, S; Mortada, ND; Nasr, M | 1 |
| Joshi, VY; Patel, AR | 1 |
| Kang, JS; Lee, MH; Park, JH; Park, YS; Rhim, SY; Shaw, LM | 1 |
| Anju, P; Kushtagi, P; Manoj, K; Mutalik, S; Ranjith, AK; Reddy, MS; Udupa, N; Usha, AN | 1 |
| Alvarez-Soria, MA; Calvo, E; Egido, J; Herrero-Beaumont, G; Largo, R; Moreno-Rubio, J; Santillana, J | 1 |
| Kushtagi, P; Mutalik, S; Ranjith, AK; Reddy, MS; Udupa, N; Usha, AN | 1 |
| Elshamy, AA; Mansour, S; Mortada, ND; Nasr, M | 1 |
| De Klippel, N; Giurgea, S; Herroelen, L; Jacquy, J; Louis, P; Monseu, G; Schoenen, J; Vandenheede, M | 1 |
| Devkhile, AB; Shaikh, KA | 1 |
| Ahuja, A; All, J; Baboota, S; Shafiq, S; Shakeel, F | 1 |
| Arumugam, K; Averineni, RK; Meka, SR; Nayak, U; Nayanabhirama, U; Shavi, GV; Sureshwar, P | 1 |
| Barceló, D; Pérez, S | 1 |
| Dabholkar, P; Das, V; Grawal, SP; Khattri, S; Nath, R; Nischal, A; Pant, KK; Singh, A | 1 |
| Ojha, A; Padh, H; Rathod, R | 1 |
| Bartakke, G; Chandurkar, N; Desai, M; Kini, S; Pareek, A; Sharma, VD | 1 |
| Burstein, R; Jakubowski, M | 1 |
| Jadhav, KR; Jadhav, SL; Kadam, VJ; Pisal, SS; Shaikh, IM | 1 |
| Ambade, R; Bartakke, G; Chandanwale, AS; Chandurkar, N; Gupta, A; Pareek, A | 1 |
| Parikh, JR; Parikh, RH; Solanki, AB; Vadher, AH | 1 |
| Dahiya, R; Pathak, K; Ramadan, WM; Sarpal, AS; Singh, AP | 1 |
| Chotai, NP; Hingorani, L; Nagda, C; Patel, P; Patel, S; Patel, U; Soni, T | 1 |
| Derry, S; McQuay, HJ; Moore, RA | 1 |
| Chakraborty, S; Khandai, M; Patra, ChN; Patro, VJ; Sen, KK; Sharma, A | 1 |
| Fernández-Jorge, B; Fonseca, E; Goday-Buján, JJ; Molina, FP; Murga, M; Pérez-Varela, L | 1 |
| Baird, JA; Taylor, LS | 1 |
| Awari, JG; Kilor, VA; Sapkal, NP; Shewale, BD | 1 |
| Li, Q; Zheng, J; Zhou, Z | 1 |
| Andrade, RJ; Gálvez, J; Hallal, H; Titos-Arcos, JC | 1 |
| Kumar, CK; Rasheed, A | 1 |
| Harris, MT; Taylor, LS; Zhu, Q | 1 |
| Agrawal, SN; Chandurkar, NB; Pareek, A; Patil, RT; Tambe, SG; Uday, RB | 1 |
| Dua, K; Pabreja, K; Padi, SS | 1 |
| Gilhotra, RM; Mathurm, M | 1 |
| Reddy, KB; Suresh, S; Thiruganesh, R; Umadevi, SK | 1 |
| Chakraborty, S; Dinda, SC; Khanam, N; Khandai, M; Patra, ChN; Sen, KK; Sharma, A | 1 |
| Dua, K; Pabreja, K; Ramana, MV | 1 |
| Chandurkar, N; Dalal, B; Gupta, A; Jesalpura, B; Mehrotra, A; Mukherjee, A; Pareek, A; Sirsikar, A | 1 |
| Afonso, A; Cardoso, J; Carvalho, R; Fernandes, C | 1 |
| Borde, LC; Choudhari, YM; Inamdar, NN; Kulthe, SS; Mourya, VK; Shirolikar, SM | 1 |
| Penina, GO; Starikov, AS | 1 |
| Awasthi, SS; Dharmendra, K; Kymonil, KM; Manisha, P | 1 |
| Bae, SK; Kim, SH; Lee, HJ; Lee, HW; Lee, SH; Lim, MS; Seong, SJ; Shin, SY; Yoon, YR | 1 |
| Karthikeyan, K; Korrapati, PS; Lakra, R; Rajaram, R | 1 |
| Chawla, V; Saraf, SA | 1 |
| Woo, YA | 1 |
| Attrey, SD; Bansal, YS; Joshi, R; Medhi, B; Pandhi, P; Prakash, A; Singh, D | 1 |
| Acharjya, B; Chakraborty, S; Chakravarthi, G; Ghosh, AK; Khandai, M; Krishna, NB; Nayak, P | 1 |
| Desai, PP; Mehta, PJ; Patel, NR; Sherikar, OD | 1 |
| Dey, S; Gupta, SD; Khila, S; Mahanti, B; Mazumder, B | 1 |
| Ahn, B; Gwak, Hs; Kang, W; Kim, E; Noh, K | 1 |
| Choi, SK; Lee, BJ; Lim, J; Park, JB; Tran, PH; Tran, TT | 1 |
| Chu, KR; Jeong, SH; Lee, E; Park, ES | 1 |
| Guhathakarta, S; Karthikeyan, K; Korrapati, PS; Rajaram, R | 1 |
| Lahoti, G | 1 |
| Chang, IC; Chang, JK; Lee, MY; Tsou, HK; Wei, JC; Yeo, K; Yu, CT | 1 |
| Katara, R; Majumdar, DK | 1 |
| Mumtaz, A; Naseem, A; Nazir, R; Sattar, AA | 1 |
| Choudhury, S; Dasgupta, S; Dey, S; Mazumder, B | 1 |
| Guru, PR; Nayak, AK; Sahu, RK | 1 |
| Basu, SK; Jana, S; Nayak, AK; Saha, A; Sen, KK | 1 |
| Chi, SC; Nguyen, T; Park, ES; Rhee, YS | 1 |
| Basu, SK; Das, A; Jana, S; Nayak, AK; Sen, KK | 1 |
| Agozzino, M; Ardigò, M; Berardesca, E; Conti, A; Di Lernia, V; Longo, C; Pellacani, G | 1 |
| Ramasamy, T; Ruttala, HB; Shanmugam, S; Umadevi, SK | 1 |
| Chandurkar, N; Pareek, A | 1 |
| Pathak, K; Sharma, P | 1 |
| Gupta, SK; Kumar, S | 1 |
| Aggarwal, P; Cruz, SD; Gupta, M; Nada, R | 1 |
| Lee, BJ; Tran, PH; Tran, TT | 1 |
| Gaur, PK; Mishra, S; Purohit, S | 1 |
| Hasnain, MS; Kalia, S; Nayak, AK | 1 |
| Bae, KS; Choi, HY; Kim, MJ; Kim, SE; Kim, YH; Lim, HS; Noh, YH; Park, KM | 1 |
| Basu, SK; Jana, S; Manna, S; Nayak, AK; Sen, KK | 1 |
| Dasgupta, S; Ghosh, SK; Mazumder, B; Ray, S | 1 |
| Patel, PN; Samanthula, G; Shrigod, VV | 1 |
| Abhinav, C; Chauhan, PS; Mahajan, VK; Mehta, KS | 1 |
| Kumar, D; Sailaja Chirravuri, SV; Shastri, NR | 1 |
| Deshmukh, RK; Naik, JB | 2 |
| Cho, YH; Choe, HS; Han, CH; Lee, SJ; Shim, BS | 1 |
| Basu, SK; Jana, S; Sen, KK | 1 |
| M, K; Shastri, NR; Sistla, R | 1 |
| Kale, MA; Nawale, RB; Shelke, R | 1 |
| Gunasekaran, S; Srinivasan, S; Suresh, S | 1 |
| Gandhi, TR; Maulvi, FA; Soni, TG; Thakkar, VT | 1 |
| Jeong, TC; Kang, W; Kim, E; Kwon, KI; Noh, K; Shin, BS; Yun, HY | 1 |
| Gauglitz, G; Hilbig, U; Rau, S | 1 |
| Aeri, V; Gaur, PK; Mishra, S | 1 |
| Chung, H; Duy, PK; Park, S; Shin, K; Woo, YA | 1 |
| Cho, JW; Choi, MG; Chung, IK; Jang, JY; Kang, DH; Kim, JI; Kim, KO; Kim, TO; Lee, DH; Lee, KM; Lee, OY; Lee, ST; Lee, SW; Rew, JS; Seol, SY; Shin, YW | 1 |
| Karthikeyan, K; Korrapati, PS; Vijayalakshmi, E | 1 |
| Bishnoi, M; Hurkat, P; Jain, A; Jain, SK | 1 |
| Katare, OP; Kaur, M; Kumar, M; Kumar, P; Malik, R; Raza, K; Sharma, G | 1 |
| Cho, CS; Kang, YM; Kim, JH; Kim, SK; Lee, DH; Lee, SK; Lee, ST; Lee, YC; Park, SH; Park, W; Park, YW; Rew, JS; Yoo, WH | 1 |
| Gandhi, A; Jana, S; Sen, KK; Sheet, S | 1 |
| Dewan, I; Islam, SM; Miah, S; Rana, S | 1 |
| Jani, GK; Maheriya, PM; Moradiya, NG; Nagar, BJ; Prajapati, VD; Randeria, NP | 1 |
| Bhandari, AB; Dhokchawle, BV | 1 |
| Jana, S; Nayak, AK; Samanta, A; Sen, KK | 1 |
| Boakye, CH; Godugu, C; Mendonca Faria, HA; Patel, AR; Singh, M; Somagoni, J; Zucolotto, V | 1 |
| Ali, N; Dave, V; Sharma, S; Vishwakarma, P; Yadav, S | 1 |
| Ganesh, M; Hemalatha, P; Jang, HT; Jeon, UJ; Peng, MM; Saravanakumar, A; Ubaidulla, U | 1 |
| Dave, V; Paliwal, S; Sharma, S; Yadav, S | 1 |
| Bindu, DT; Chowdary, VH; Haritha, K; Raju, YP; Satyanarayana, RP; Vandana, KR; Vinesha, V | 1 |
| Dwivedi, H; Kymonil, KM; Saraf, SA; Tiwari, S | 1 |
| Jana, S; Laha, B; Maiti, S | 1 |
| Jain, NK; Mongia, P; Raj, R; Ram, A | 1 |
| Cheon, YK; Choi, JS; Do, JH; Lee, TY; Oh, HC; Song, TJ | 1 |
| Pragada, RR; Sanka, K; Veerareddy, PR | 1 |
| Batinić, BB; Gašperlin, M; Lukić, MŽ; Marković, BD; Ranđelović, DV; Savić, MM; Savić, SD; Todosijević, MN | 1 |
| Cekić, N; Daniels, R; Isailović, T; Lukić, M; Marković, B; Pantelić, I; Ranđelović, D; Savić, S; Ðorđević, S | 1 |
| Alderson, D; Chipangura, J; Cuthbert, RJ; Galligan, TH; Naidoo, V; Prakash, VM; Svobodova, D; Taggart, MA | 1 |
| Joseph, J; Mathew, SE; Menon, D; Nair, SV; Neppalli, MH; Padmakumar, S; Shankarappa, SA | 1 |
| Goyal, H; Katare, OP; Raza, K; Sharma, G; Thakur, K | 1 |
| Choi, JS; Lee, BJ; Meghani, N; Park, JJ | 1 |
| Elshahed, MS; Hegazy, MA; Helmy, MI; Toubar, SS | 1 |
| Anand, D; Katare, OP; Kumar, M; Pareek, A; Raza, K; Sharma, G; Singh, J | 1 |
| A, MS; S, P | 1 |
| Dong, L; Liu, G; Liu, S; Lu, K; Zheng, Y | 1 |
| Banerjee, A; Jana, S; Maiti, S; Sen, KK | 1 |
| Acharya, GB; Basnet, RB; Kc, HB; Shah, AK; Shrestha, A; Shrestha, PM | 1 |
| Lee, BJ; Nguyen, VH; Van Nguyen, H | 1 |
| Ihm, C; Kang, W; Kim, E | 1 |
| Garg, NK; Katare, OP; Nirbhavane, P; Sharma, G; Shukla, R; Singh, B; Tyagi, RK | 1 |
| Ayyıldız, N; Taşdemir, A; Taşkıran, M | 1 |
| Kaur, M; Sharma, S; Sinha, VR | 1 |
| Athar, F; Dohare, N; Khan, AB; Maurya, N; Patel, R; Singh, P; Thakur, S | 1 |
| Garg, NK; Goni, VG; Kapil, N; Katare, OP; Pareek, A; Raza, K; Saini, MK; Sharma, G; Thakur, K | 1 |
| Choi, YW; Kang, WH; Lee, BJ; Nguyen, HV; Park, C | 1 |
| Jung, WC; Kang, YM; Kim, HS; Kim, JH; Lee, BH; Lee, HM; Moon, SH; Suk, KS; Yang, JH | 1 |
| Garg, NK; Jain, A; Jain, S; Katare, OP; Sharma, G; Singh, B; Tyagi, RK | 1 |
| Jana, S; Sen, KK | 1 |
| Park, JS; Seo, KW; Shin, JH; Tahk, SJ | 1 |
| Katara, R; Majumdar, DK; Sachdeva, S | 3 |
| Abhijeet, K; Namita, D | 1 |
| Poorvashree, J; Suneela, D | 1 |
| Hussain, Z; Ibrahim, K; Khan, MA; Khan, S; Rahim, H; Sadiq, A; Shah, SMH; Shahat, AA; Ullah, R | 1 |
| Ali, H; Bashir, L; Muhammad, IN; Naz, S; Shoaib, MH; Siddiqui, F; Yasmin, R; Zafar, F | 1 |
| Alam, S; Ali, H; Aslam, N; Bushra, R; Shafiq, Y; Shoaib, MH; Zafar, F | 1 |
| Belal, F; Derayea, S; Hammad, MA; Omar, MA; Saleh, SF; Zayed, S | 1 |
| Elshahed, MS; Hegazy, MA; Helmy, MI; Mohamed, D; Toubar, SS | 1 |
| Ali, S; Hasnain, MS; Nayak, AK; Rishishwar, P; Rishishwar, S | 1 |
| Biju, IK; Manappallil, RG; Peringat, J; Prasan, D | 1 |
| Fernández-Torres, J; López-Reyes, A; Martínez-Flores, K; Martínez-Nava, GA; Zamudio-Cuevas, Y | 1 |
| Boatto, G; Burrai, L; Chegaev, K; Cristiano, C; De Caro, C; Gazzano, E; Lazzarato, L; Magliocca, S; Marabello, D; Marini, E; Nieddu, M; Riganti, C; Rimoli, MG; Rolando, B; Russo, R; Sodano, F | 1 |
| Chhabra, N; Prabha, N | 1 |
| Bang, WJ; Cho, JS; Cho, ST; Choo, MS; Ko, K; Lee, SH; Lee, WK; Lee, YG; Oh, CY; Shin, TY; Yang, DY | 1 |
| Batinić, B; Ilić, T; Lunter, D; Marković, B; Savić, M; Savić, S; Schmidberger, M | 1 |
| Cho, SM; Choi, YW; Chung, SE; Jeong, HM; Kang, WH; Kim, TH; Lee, DY; Lim, JY; Nam, KY; Shin, BS; Shin, S; Song, CH; Thapa, SK | 1 |
| Abid, HR; Al Haydar, M; Sunderland, B; Wang, S | 1 |
| Ali, H; Ali, T; Nasiri, MI; Qazi, F; Shoaib, MH; Yasmin, R; Zafar, F | 1 |
| Alshaikh, RA; El Maghraby, GM; Essa, EA | 1 |
| El-Bagary, RI; El-Hakeem, MM; Mahrouse, MA; Megally, AB; Mohamed, AA | 1 |
| Bonacucina, G; Cespi, M; Elmowafy, E; Soliman, ME | 1 |
| Akhila, M; Alwala, A; Badam, R; Bontala, P; Chaitanya, NC; Chintada, S; Inamdar, P; Mannava, H; Saawarn, N; Siva Prasad Reddy, G; Srinivas, P | 1 |
| Materkowski, M | 1 |
| Ahmed, FR; Ali, H; Qazi, F; Shoaib, MH; Yasmin, R; Zafar, F | 1 |
| Gromova, OA; Putilina, MV; Rudakov, KV; Stakhovskaia, LV; Torshin, IY | 1 |
| Abd El-Rahman, MK; Ahmed, DA; Lotfy, HM; Weshahy, SA | 1 |
| Adel Ali Youssef, A; Banala, N; Dudhipala, N; Phasha Mohammed, R | 1 |
| Akhverdyan, YR; Papichev, EV; Polyakova, YV; Sivordova, LE; Zavodovsky, BV | 1 |
| Asim, MH; Ijaz, M; Jianxian, C; Murtaza, G; Saleem, K; Ur-Rehman, M | 1 |
| Gupta, A; Kumar, S; Prasad, R; Singh, S | 1 |
| Ali, H; Bushra, R; Ghayas, S; Shoaib, MH | 1 |
| Chang, MJ; Han, SB; Kang, SB; Kim, KI; Kim, MK; Kim, SH; Lee, HJ; Lee, S; Moon, YW; Park, HG; Shin, JY; Yoo, JD | 1 |
| Ahmad, J; Ahmad, MZ; Alam, MS; Algahtani, MS; Kohli, K; Shafiq-Un-Nabi, S; Warsi, MH | 1 |
| Amin, F; Bari, A; Farooq, U; Mahmood, HM; Rahim, H; Sadiq, A; Ullah Jan, N; Ullah, R | 1 |
| Mallick, S; Mishra, SA; Nandi, S; Sahoo, RN; Swain, R | 1 |
| Gupta, A; Kumar, S; Mishra, CK; Singh, S | 1 |
| Chatterjee, B; Saleh, MSM; Sammour, RMF; Shahiwala, A; Taher, M | 1 |
| Chiranjeevi, P; Kumar, KV; Nagappan, K; Peraman, R; Reddy, YP; Vasantharaju, SG | 1 |
| Butakova, JS; Parshin, MS; Samartsev, IN; Zhivolupov, SA | 1 |
| Abou-Taleb, HA; Ibrahim, MA; Yassin, HA | 1 |
| Kang, M; Kim, B; Kim, MG; Moon, SJ; Shin, N | 1 |
| Chandramohan, S; Gaur, GK; Green, RE; Kesavan, M; Mahendran, K; Mallord, JW; Mathesh, K; Naidoo, V; Pawde, AM; Prakash, N; Prakash, VM; Ranade, S; Saikia, D; Sharma, AK; Shringarpure, R | 1 |
| Abd El-Aty, AM; Bang, JS; Chung, YH; Jeong, JC; Jeong, JH; Jung, TW; Park, SY; Park, T | 1 |
| Gaidukevič, J; Górska, A; Paczosa-Bator, B; Piech, R | 1 |
| Prajapati, P; Pulusu, VS; Shah, S | 1 |
18 review(s) available for diclofenac and aceclofenac
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[NSAID-induced hepatotoxicity: aceclofenac and diclofenac].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Cholestasis; Diclofenac; Female; Humans; Male; Middle Aged | 1995 |
[Aceclofenac-induced hepatitis].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Diclofenac; Female; Humans | 1995 |
Aceclofenac. A review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain management.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Diclofenac; Humans; Pain; Rheumatic Diseases | 1996 |
[Pharma-clinics. The drug of the month. Aceclofenac (Biofenac)].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Joint Diseases; Pain | 1999 |
Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cartilage Oligomeric Matrix Protein; Diclofenac; Disease Management; Drug Tolerance; Extracellular Matrix Proteins; Glycoproteins; Humans; Matrilin Proteins; Pain; Rheumatic Diseases | 2001 |
[What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cartilage; Chronic Disease; Diclofenac; Humans; Inflammation; Osteoarthritis; Pain; Spondylitis, Ankylosing | 2001 |
Aceclofenac in the management of inflammatory pain.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topic; Diclofenac; Humans; Inflammation; Osteoarthritis; Pain; Spondylitis, Ankylosing | 2004 |
Drug metabolism by cultured human hepatocytes: how far are we from the in vivo reality?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cytochrome P-450 Enzyme System; Diclofenac; Genetic Variation; Hepatocytes; Humans; Liver; Multigene Family; Pharmaceutical Preparations | 2004 |
[Aceclofenac (aertal) in rheumatological practice].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Diclofenac; Humans; Rheumatic Diseases | 2005 |
Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biotransformation; Cells, Cultured; Cytochrome P-450 Enzyme System; Diclofenac; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Genetic Variation; Hepatocytes; Humans; In Vitro Techniques; Inactivation, Metabolic; Metabolic Networks and Pathways; Models, Biological; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics | 2007 |
Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry--do they comply with FDA recommendations?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Culture Techniques; Cells, Cultured; Data Collection; Data Interpretation, Statistical; Diclofenac; Drug Industry; Drug-Related Side Effects and Adverse Reactions; Enzyme Induction; Enzymes; Guideline Adherence; Health Planning Guidelines; Humans; Molecular Structure; Pharmaceutical Preparations; United States; United States Food and Drug Administration | 2007 |
Single dose oral aceclofenac for postoperative pain in adults.
Topics: Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Pain, Postoperative | 2009 |
[Aceclofenac-induced acute cholestatic lesion].
Topics: Acute Disease; Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Diclofenac; Fatty Liver; HLA-B27 Antigen; Humans; Jaundice, Obstructive; Male; Middle Aged | 2010 |
Topical delivery of aceclofenac: challenges and promises of novel drug delivery systems.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Delivery Systems; Inflammation; Osteoarthritis | 2014 |
Aceclofenac: Species-Dependent Metabolism and Newer Paradigm Shift from Oral to Non-oral Delivery.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Administration Routes; Drug Carriers; Drug Stability; Humans; Solubility; Species Specificity | 2017 |
Emergent nanotherapies in microcrystal-induced arthritis.
Topics: Animals; Calcium Phosphates; Chitosan; Chondrocalcinosis; Crystal Arthropathies; Diclofenac; Disease Models, Animal; Gold; Humans; Inflammation Mediators; Nanoparticles; Peptide Hydrolases; Urate Oxidase; Uric Acid | 2018 |
[Kompleksowe spojrzenie na chorobę zwyrodnieniową stawów - zastosowanie aceklofenaku w leczeniu tej jednostki chorobowej].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Administration Schedule; Humans; Low Back Pain; Osteoarthritis; Pain Measurement; Treatment Outcome | 2019 |
53 trial(s) available for diclofenac and aceclofenac
| Article | Year |
|---|---|
Evaluation of the analgesic activity and tolerability of aceclofenac in the treatment of post-episiotomy pain.
Topics: Acetaminophen; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Episiotomy; Female; Humans; Pain Measurement; Pain, Postoperative; Random Allocation | 1989 |
Aceclofenac and paracetamol in episiotomal pain.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Episiotomy; Female; Humans; Pain, Postoperative; Pregnancy | 1988 |
Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Diclofenac; Dinoprostone; Double-Blind Method; Female; Humans; Interleukin-1; Interleukin-6; Knee Joint; Leukotriene B4; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Osteoarthritis; Platelet Activating Factor; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 1994 |
Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Double-Blind Method; Drug Tolerance; Female; Humans; Ketoprofen; Male; Middle Aged; Pain; Prospective Studies | 1995 |
Comparison of aceclofenac with diclofenac in the treatment of osteoarthritis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Humans; Knee Joint; Male; Middle Aged; Osteoarthritis; Treatment Outcome | 1995 |
The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis.
Topics: Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Elasticity; Female; Hand Strength; Heartburn; Humans; Indomethacin; Joints; Male; Middle Aged; Pain Measurement; Statistics, Nonparametric; Treatment Outcome; Vertigo | 1996 |
Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis.
Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Participation; Piroxicam; Placebos; Spondylitis, Ankylosing; Surveys and Questionnaires | 1996 |
The efficacy and tolerability of aceclofenac in the treatment of patients with ankylosing spondylitis: a multicenter controlled clinical trial. Aceclofenac Indomethacin Study Group.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Humans; Indomethacin; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Patient Participation; Spondylitis, Ankylosing; Time Factors | 1996 |
A multi-centre, double-blind comparative study of the efficacy and safety of aceclofenac and diclofenac in the treatment of rheumatoid arthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Long-Term Care; Male; Middle Aged; Pain Measurement; Range of Motion, Articular; Treatment Outcome | 1995 |
Aceclofenac in rheumatoid arthritis: a useful and novel anti-inflammatory.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Double-Blind Method; Female; Humans; Male; Middle Aged; Range of Motion, Articular; Treatment Outcome | 1996 |
Comparative study of the efficacy and safety of aceclofenac and tenoxicam in rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Piroxicam | 1996 |
Comparison of aceclofenac with piroxicam in the treatment of osteoarthritis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle Aged; Osteoarthritis; Pain Measurement; Piroxicam | 1997 |
Aceclofenac is a well-tolerated alternative to naproxen in the treatment of osteoarthritis.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Diclofenac; Double-Blind Method; Drug Administration Schedule; Edema; Erythema; Female; Humans; Knee Joint; Male; Middle Aged; Naproxen; Osteoarthritis; Pain Measurement; Range of Motion, Articular; Treatment Outcome | 1997 |
[Comparative, randomized, parallel clinical study of the effectiveness and safety of aceclofenac vs. paracetamol in the treatment of viral pharyngoamygdalitis].
Topics: Acetaminophen; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans; Male; Middle Aged; Pharyngitis; Severity of Illness Index; Tonsillitis | 1997 |
[Efficacy and safety of nabumetone in the treatment of knee osteoarthritis: a comparative clinical trial versus aceclofenac. Study Group of Nabumetone for Osteoarthritis of the Knee].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Butanones; Diclofenac; Female; Humans; Knee Joint; Male; Middle Aged; Nabumetone; Osteoarthritis | 1997 |
The comparative efficacy of aceclofenac and ibuprofen in postoperative pain after third molar surgery.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Chi-Square Distribution; Diclofenac; Double-Blind Method; Female; Humans; Ibuprofen; Linear Models; Male; Molar, Third; Pain Measurement; Pain, Postoperative; Tooth Extraction; Treatment Outcome | 1998 |
Simultaneous determination of aceclofenac and diclofenac in human plasma by narrowbore HPLC using column-switching.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Diclofenac; Humans; Indicators and Reagents; Male; Reproducibility of Results | 2000 |
Bioequivalence of two aceclofenac tablet formulations after a single oral dose to healthy male Korean volunteers.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Chromatography, High Pressure Liquid; Diclofenac; Humans; Male; Tablets; Therapeutic Equivalency | 2001 |
Preparation and evaluation of aceclofenac microemulsion for transdermal delivery system.
Topics: Administration, Cutaneous; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Creatine Kinase; Diclofenac; Drug Compounding; Emulsions; Excipients; Exercise; Humans; L-Lactate Dehydrogenase; Male; Muscular Diseases; Rats; Rats, Sprague-Dawley; Skin Absorption; Solubility | 2002 |
A double-blind, multicentre, randomised clinical trial comparing the efficacy and tolerability of aceclofenac with diclofenac resinate in patients with acute low back pain.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Humans; Low Back Pain; Male; Middle Aged; Pain Measurement; Spinal Diseases; Treatment Outcome | 2003 |
Simultaneous determination of aceclofenac and three of its metabolites in human plasma by high-performance liquid chromatography.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Biotransformation; Chromatography, High Pressure Liquid; Diclofenac; Half-Life; Humans; Male; Reproducibility of Results; Spectrophotometry, Ultraviolet | 2003 |
Aceclofenac spares cyclooxygenase 1 as a result of limited but sustained biotransformation to diclofenac.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Biotransformation; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Delayed-Action Preparations; Diclofenac; Female; Humans; In Vitro Techniques; Isoenzymes; Kinetics; Male; Membrane Proteins; Monocytes; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2003 |
Bioequivalence evaluation of two brands of aceclofenac 100 mg tablets (Aceclofar and Bristaflam) in healthy human volunteers.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Chromatography, High Pressure Liquid; Cross-Over Studies; Diclofenac; Humans; Linear Models; Male; Tablets; Therapeutic Equivalency | 2004 |
Trials of clear aceclofenac-loaded soft capsules with accelerated oral absorption in human subjects.
Topics: Absorption; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Biological Availability; Capsules; Chromatography, High Pressure Liquid; Cross-Over Studies; Diclofenac; Ethanolamine; Half-Life; Humans; Male; Meglumine; Polyethylene Glycols; Solubility; Spectrophotometry, Ultraviolet | 2005 |
Analgesic efficacy of aceclofenac after surgical extraction of impacted lower third molars.
Topics: Administration, Oral; Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Follow-Up Studies; Humans; Male; Mandible; Molar, Third; Pain Measurement; Pain, Postoperative; Premedication; Tablets; Time Factors; Tooth Extraction; Tooth, Impacted | 2006 |
Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blotting, Western; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Depression, Chemical; Diclofenac; Dinoprostone; Female; Gene Expression; Humans; Interleukin-1; Knee Joint; Male; Membrane Proteins; Osteoarthritis, Knee; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Synovial Membrane; Time Factors; Tumor Necrosis Factor-alpha | 2006 |
The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoea.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Dysmenorrhea; Female; Humans; Middle Aged; Naproxen; Pain Measurement; Self Administration; Treatment Outcome | 2006 |
Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an Indian experience.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Female; Humans; India; Male; Middle Aged; Osteoarthritis; Treatment Outcome | 2006 |
Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Delayed-Action Preparations; Diclofenac; Drug Administration Schedule; Drug Compounding; Drug Evaluation, Preclinical; Drug Stability; Edema; Excipients; Half-Life; Humans; Male; Metabolic Clearance Rate; Mice; Pain; Rats; Solubility; Tablets; Toxicity Tests, Chronic | 2007 |
Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: a double-blind 6-week randomized controlled trial.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Humans; Male; Middle Aged; Osteoarthritis, Knee; Treatment Outcome | 2007 |
Bioequivalence and pharmacokinetic evaluation of two branded formulations of aceclofenac 100 mg: a single-dose, randomized, open-label, two-period crossover comparison in healthy Korean adult volunteers.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Cross-Over Studies; Diclofenac; Dose-Response Relationship, Drug; Drug Tolerance; Female; Follow-Up Studies; Humans; Korea; Male; Osteoarthritis; Pain; Reference Values; Therapeutic Equivalency | 2008 |
Chitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Cellulose; Chemistry, Pharmaceutical; Chitosan; Cross-Over Studies; Delayed-Action Preparations; Diclofenac; Double-Blind Method; Drug Administration Schedule; Drug Carriers; Drug Compounding; Drug Stability; Humans; Hydrogen-Ion Concentration; Methylcellulose; Microscopy, Electron, Scanning; Solubility; Spectrophotometry, Infrared; Surface Properties; Tablets, Enteric-Coated; Technology, Pharmaceutical; Therapeutic Equivalency | 2008 |
Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cartilage, Articular; Celecoxib; Chondrocytes; Cyclooxygenase 2; Diclofenac; Dinoprostone; Down-Regulation; Female; Humans; Interleukin-1; Male; Nitric Oxide; Osteoarthritis, Knee; Pyrazoles; Sulfonamides; Synovial Membrane | 2008 |
Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Migraine Disorders; Multivariate Analysis; Physical Stimulation; Pilot Projects; Prevalence; Serotonin Receptor Agonists; Somatosensory Disorders; Treatment Outcome; Tryptamines | 2008 |
A randomized, multicentric, comparative evaluation of aceclofenac-paracetamol combination with aceclofenac alone in Indian patients with osteoarthritis flare-up.
Topics: Acetaminophen; Adult; Aged; Diclofenac; Drug Therapy, Combination; Female; Humans; India; Male; Middle Aged; Osteoarthritis; Pain Measurement | 2009 |
Aceclofenac-tizanidine in the treatment of acute low back pain: a double-blind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone.
Topics: Activities of Daily Living; Acute Disease; Adolescent; Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Clonidine; Diclofenac; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy; Drug Therapy, Combination; Female; Humans; Low Back Pain; Male; Middle Aged; Mobility Limitation; Movement; Outcome Assessment, Health Care; Pain Measurement; Pain Threshold; Patient Satisfaction; Placebo Effect; Range of Motion, Articular; Treatment Outcome; Young Adult | 2009 |
Efficacy and safety of aceclofenac and drotaverine fixed-dose combination in the treatment of primary dysmenorrhoea: a double-blind, double-dummy, randomized comparative study with aceclofenac.
Topics: Adolescent; Adult; Analgesics; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Drug Combinations; Dysmenorrhea; Female; Humans; Papaverine; Phosphodiesterase Inhibitors; Treatment Outcome; Young Adult | 2010 |
Efficacy and safety of aceclofenac-cr and aceclofenac in the treatment of knee osteoarthritis: a 6-week, comparative, randomized, multicentric, double-blind study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Diclofenac; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Osteoarthritis, Knee; Pain Measurement; Treatment Outcome | 2011 |
[The efficiency of aceclofenac in acute vertebrogenic compression-ischemic syndrome].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans; Ischemia; Low Back Pain; Lumbar Vertebrae; Male; Middle Aged; Radiculopathy; Spinal Cord Compression | 2011 |
Pharmacokinetics of a new once-daily controlled-release formulation of aceclofenac in Korean healthy subjects compared with immediate-release aceclofenac and the effect of food: a randomized, open-label, three-period, crossover, single-centre study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Delayed-Action Preparations; Diclofenac; Dietary Fats; Drug Administration Schedule; Food-Drug Interactions; Humans; Male; Republic of Korea; Therapeutic Equivalency; Young Adult | 2012 |
Tramadol/acetaminophen combination as add-on therapy in the treatment of patients with ankylosing spondylitis.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dizziness; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Nausea; Pain Measurement; Quality of Life; Severity of Illness Index; Spondylitis, Ankylosing; Tramadol; Treatment Outcome | 2013 |
Psoriasis plaque test with confocal microscopy: evaluation of different microscopic response pathways in NSAID and steroid treated lesions.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Dermoscopy; Diclofenac; Drug Monitoring; Epidermis; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Microscopy, Confocal; Psoriasis; Treatment Outcome | 2013 |
Comparison of gastrointestinal safety and tolerability of aceclofenac with diclofenac: a multicenter, randomized, double-blind study in patients with knee osteoarthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Tract; Humans; Male; Middle Aged; Osteoarthritis, Knee; Pain; Pain Measurement; Treatment Outcome | 2013 |
Pharmacokinetic interactions between eperisone hydrochloride and aceclofenac: a randomized, open-label, crossover study of healthy Korean men.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blockers; Cross-Over Studies; Diclofenac; Drug Interactions; Drug Therapy, Combination; Healthy Volunteers; Humans; Male; Muscle Relaxants, Central; Propiophenones; Republic of Korea; Therapeutic Equivalency; Young Adult | 2013 |
Clinical efficacy of roxithromycin in men with chronic prostatitis/chronic pelvic pain syndrome in comparison with ciprofloxacin and aceclofenac: a prospective, randomized, multicenter pilot trial.
Topics: Adult; Chronic Disease; Ciprofloxacin; Diclofenac; Humans; Male; Pelvic Pain; Pilot Projects; Prospective Studies; Prostatitis; Roxithromycin; Treatment Outcome; Young Adult | 2014 |
A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Double-Blind Method; Female; Humans; Middle Aged; Misoprostol; Peptic Ulcer; Plant Extracts; Young Adult | 2014 |
Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicity.
Topics: Adult; Aged; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Butanones; Diclofenac; Double-Blind Method; Drug Administration Schedule; Gastric Mucosa; Humans; Meloxicam; Middle Aged; Misoprostol; Nabumetone; Quinolones; Stomach Ulcer; Thiazines; Thiazoles; Treatment Outcome | 2014 |
Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopic Retrograde; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Pancreatitis; Phosphodiesterase 5 Inhibitors; Prospective Studies; Pyrimidines; Republic of Korea; Risk Factors; Sulfonamides; Treatment Outcome; Young Adult | 2015 |
Tamsulosin versus tadalafil as a medical expulsive therapy for distal ureteral stones: A prospective randomized study.
Topics: Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Diclofenac; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pain Measurement; Prospective Studies; Renal Colic; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Ureteral Calculi; Urological Agents; Young Adult | 2016 |
Efficacy and Safety of Different Aceclofenac Treatments for Chronic Lower Back Pain: Prospective, Randomized, Single Center, Open-Label Clinical Trials.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Administration Schedule; Female; Humans; Low Back Pain; Male; Middle Aged; Pain Measurement; Prospective Studies; Quality of Life; Treatment Outcome | 2017 |
Is A Combination of Antibiotics and Non-Steroidal Anti-Inflammatory Drugs More Beneficial Than Antibiotic Monotherapy For The Treatment of Female Acute Uncomplicated Cystitis? A Randomized Controlled Pilot Study.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cefpodoxime; Ceftizoxime; Cystitis; Diclofenac; Drug Therapy, Combination; Dysuria; Female; Humans; Middle Aged; Pain Measurement; Pilot Projects; Prospective Studies; Symptom Assessment | 2018 |
Efficacy and safety of short-term use of a pelubiprofen CR and aceclofenac in patients with symptomatic knee osteoarthritis: A double-blinded, randomized, multicenter, active drug comparative, parallel-group, phase IV, non-inferiority clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Equivalence Trials as Topic; Female; Humans; Male; Middle Aged; Osteoarthritis, Knee; Pain Measurement; Patient Safety; Phenylpropionates; Treatment Outcome | 2020 |
Pharmacokinetic Interactions Between Tegoprazan and Naproxen, Aceclofenac, and Celecoxib in Healthy Korean Male Subjects.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Benzene Derivatives; Celecoxib; Cross-Over Studies; Diclofenac; Humans; Imidazoles; Male; Naproxen; Republic of Korea; Tablets | 2022 |
216 other study(ies) available for diclofenac and aceclofenac
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Enthalpic Forces Correlate with the Selectivity of Transthyretin-Stabilizing Ligands in Human Plasma.
Topics: Amyloidosis; Calorimetry; Drug Design; Humans; Ligands; Models, Molecular; Plasma; Prealbumin; Protein Binding; Thermodynamics; X-Ray Diffraction | 2015 |
Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Benzoquinones; Capillary Permeability; Carrageenan; Diclofenac; Edema; Female; Granuloma; Indomethacin; Male; Mice; Naproxen; Pain; Phenylbutazone; Pleurisy; Rats; Rats, Inbred Strains; Silver Nitrate; Stomach Ulcer; Synovitis | 1991 |
The pharmacological profile of aceclofenac, a new nonsteroidal antiinflammatory and analgesic drug.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dogs; Female; Indomethacin; Male; Mice; Naproxen; Phenylbutazone; Rats; Rats, Inbred Strains; Stomach Ulcer | 1991 |
Comparative study of the gastrointestinal tolerance of diclofenac and aceclofenac.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Male; Rats; Rats, Inbred Strains | 1988 |
[Refractory idiopathic liquefying panniculitis].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Azathioprine; Diclofenac; Drug Resistance; Female; Humans; Panniculitis, Nodular Nonsuppurative; Prednisone | 1995 |
[Aceclofenac and mental confusion].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Confusion; Diclofenac; Humans; Knee Joint; Male | 1994 |
[Vasculitis from hypersensitivity and aceclofenac].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Male; Vasculitis | 1993 |
Leukocytoclastic vasculitis and hemoptysis after treatment with aceclofenac.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Hemoptysis; Humans; Vasculitis, Leukocytoclastic, Cutaneous | 1995 |
Aceclofenac, a new nonsteroidal antiinflammatory drug, decreases the expression and function of some adhesion molecules on human neutrophils.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Cell Adhesion; Cell Adhesion Molecules; Dexamethasone; Diclofenac; Endothelium, Vascular; Flow Cytometry; Humans; In Vitro Techniques; Neutrophils | 1996 |
Comparison of the anti-inflammatory effect and gastrointestinal tolerability of aceclofenac and diclofenac.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Diclofenac; Edema; Male; Rats; Rats, Wistar; Stomach Ulcer | 1996 |
Metabolism of aceclofenac in humans.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Diclofenac; Humans; Hydroxylation; Isoenzymes; Liver; Male; Microsomes, Liver; Reference Values | 1996 |
Comparative metabolism of the nonsteroidal antiinflammatory drug, aceclofenac, in the rat, monkey, and human.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cytosol; Diclofenac; Esterases; Female; Half-Life; Humans; In Vitro Techniques; Kinetics; Liver; Macaca fascicularis; Male; Microsomes, Liver; Rats; Species Specificity | 1996 |
[Toxic hepatitis caused by aceclofenac].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Diclofenac; Humans; Male | 1996 |
Hypersensitivity vasculitis related to aceclofenac.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans; Male; Middle Aged; Vasculitis, Leukocytoclastic, Cutaneous | 1997 |
[Hepatic toxicity caused by aceclofenac].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Diclofenac; Female; Humans; Time Factors | 1997 |
Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cells, Cultured; Chromatography, Thin Layer; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Humans; Interleukin-1; Isoenzymes; Membrane Proteins; Monocytes; Neutrophils; Prostaglandin-Endoperoxide Synthases; Synovial Membrane | 1997 |
[Methodologic comparison of the quantitative profile of aceclofenac in biological fluids].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chromatography, Liquid; Diclofenac; Humans; Reference Standards | 1997 |
Hydrolytic activity is essential for aceclofenac to inhibit cyclooxygenase in rheumatoid synovial cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Blotting, Western; Cells, Cultured; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Humans; Hydrolysis; Immunoenzyme Techniques; Isoenzymes; Membrane Proteins; Microsomes; Prostaglandin-Endoperoxide Synthases; Synovial Membrane | 1999 |
Aceclofenac: is the antiinflammatory effect really due to cyclooxygenase inhibition?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cells, Cultured; Chondrocytes; Diclofenac; Humans; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Sensitivity and Specificity | 1999 |
Spectrophotometric and spectrofluorimetric determination of etodolac and aceclofenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calibration; Capsules; Chromatography, High Pressure Liquid; Colorimetry; Diclofenac; Etodolac; Indicators and Reagents; Quality Control; Reference Standards; Reproducibility of Results; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Tablets | 1999 |
A major metabolite of aceclofenac, 4'-hydroxy aceclofenac, suppresses the production of interstitial pro-collagenase/proMMP-1 and pro-stromelysin-1/proMMP-3 by human rheumatoid synovial cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Dinoprostone; Enzyme Precursors; Extracellular Space; Humans; Interleukin-1; Matrix Metalloproteinase 1; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Protease Inhibitors; RNA, Messenger; Synovial Membrane; Tissue Inhibitor of Metalloproteinase-1 | 2000 |
[Effect of aceclofenac on thyroid hormone binding and thyroid function].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans; Male; Thyroglobulin; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 2000 |
Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cartilage, Articular; Culture Techniques; Diclofenac; Dose-Response Relationship, Drug; Extracellular Matrix; Humans; Hyaluronic Acid; Meloxicam; Osteoarthritis; Proteoglycans; Thiazines; Thiazoles | 2000 |
In vitro study of the antioxidant properties of non steroidal anti-inflammatory drugs by chemiluminescence and electron spin resonance (ESR).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Ascorbic Acid; Chlorine; Diclofenac; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; In Vitro Techniques; Indicators and Reagents; Indomethacin; Iron; Kinetics; Lipid Peroxidation; Luminescent Measurements; Neutrophil Activation; Neutrophils; Nitrates; Reactive Oxygen Species; Sodium Hypochlorite; Spectrophotometry, Ultraviolet; Sulfonamides; Tetradecanoylphorbol Acetate | 2000 |
Drug biotransformation by human hepatocytes. In vitro/in vivo metabolism by cells from the same donor.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biotransformation; Cells, Cultured; Diclofenac; Hepatocytes; Humans; Hydrolysis | 2001 |
Inhibition of tendon cell proliferation and matrix glycosaminoglycan synthesis by non-steroidal anti-inflammatory drugs in vitro.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Culture Techniques; Diclofenac; Female; Glycosaminoglycans; Humans; Indomethacin; Male; Middle Aged; Naproxen; Tendons; Wound Healing | 2001 |
Iatrogenic cost factors incorporating mild and moderate adverse events in the economic comparison of aceclofenac and other NSAIDs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Health Care Costs; Humans; Osteoarthritis; Randomized Controlled Trials as Topic; Spondylitis, Ankylosing | 2001 |
Photoallergic contact dermatitis from aceclofenac.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Dermatitis, Photoallergic; Diclofenac; Female; Humans; Osteoarthritis; Patch Tests | 2001 |
In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Chondrocytes; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytokines; Diclofenac; Dinoprostone; DNA; Humans; In Vitro Techniques; Inflammation Mediators; Interleukin-1; Isoenzymes; Membrane Proteins; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction | 2001 |
[High performance liquid chromatographic assay for aceclofenac in plasma and its pharmacokinetics in dogs].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Diclofenac; Dogs; Female; Male | 1997 |
Determination of aceclofenac in bulk and pharmaceutical formulations.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Densitometry; Diclofenac; Drug Stability; Hydrogen-Ion Concentration; Molecular Structure; Reproducibility of Results; Solvents; Spectrophotometry; Temperature | 2002 |
Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cartilage, Articular; Cells, Cultured; Chondrocytes; Culture Media, Conditioned; Diclofenac; Dinoprostone; Dose-Response Relationship, Drug; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Humans; Insulin-Like Growth Factor I; Interleukin 1 Receptor Antagonist Protein; Lipopolysaccharides; Middle Aged; Nitric Oxide; Osteoarthritis, Knee; Piroxicam; Sialoglycoproteins; Tumor Necrosis Factor-alpha | 2001 |
[Toxic hepatitis caused by aceclofenac].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Diclofenac; Female; Humans | 2001 |
Patient and physician satisfaction with aceclofenac: results of the European Observational Cohort Study (experience with aceclofenac for inflammatory pain in daily practice). Aceclofenac is the treatment of choice for patients and physicians in the manage
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cohort Studies; Diclofenac; Europe; Female; Humans; Inflammation; International Cooperation; Male; Middle Aged; Observation; Pain; Patient Compliance; Patient Satisfaction; Physicians; Practice Patterns, Physicians'; Treatment Outcome | 2002 |
Stability-indicating spectrophotometric and densitometric methods for determination of aceclofenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Capsules; Densitometry; Diclofenac; Drug Stability; Gels; Injections; Spectrophotometry, Ultraviolet; Tablets | 2002 |
[Acid coxibs, NO donors, cytokine inhibitors. New beginnings against rheumatism].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Aspirin; Cyclooxygenase Inhibitors; Cytokines; Diclofenac; Humans; Interleukin-1; Nitric Oxide Donors; Rheumatic Diseases | 2002 |
Stability indicating methods for the determination of aceclofenac.
Topics: Chromatography, High Pressure Liquid; Diclofenac; Drug Stability; Technology, Pharmaceutical | 2003 |
[Exudative erythema multiforme with transition to a toxic epidermal necrolysis after taking aceclofenac (Beofenac)].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Diclofenac; Erythema Multiforme; Female; Humans; Stevens-Johnson Syndrome | 2003 |
[Intramuscular aceclofenac and necrosis at the point of injection with fatal outcome].
Topics: Abscess; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drainage; Fatal Outcome; Female; Humans; Injections, Intramuscular; Muscle, Skeletal; Necrosis | 2003 |
Polarographic behaviour of Aceclofenac, Tenoxicam and Droxicam in a methanol-water mixture.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Methanol; Piroxicam; Polarography; Pyridines; Quality Control; Solubility; Water | 2004 |
[Function of non-steroids in dentistry and oral surgery. A favourable experiences with aceclofenac].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Dental Care; Diclofenac; Female; Humans; Male; Middle Aged; Oral Surgical Procedures; Pain Measurement; Pain, Postoperative; Patient Compliance; Treatment Outcome | 2004 |
[Determination of aceclofenac in human plasma by reversed-phase high performance liquid chromatography].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Diclofenac; Humans; Indicators and Reagents; Male | 2004 |
Separation of aceclofenac and diclofenac in human plasma by free zone capillary electrophoresis using N-methyl-D-glucamine as an effective electrolyte additive.
Topics: Adult; Diclofenac; Electrolytes; Electrophoresis, Capillary; Gluconates; Humans; Male; Meglumine | 2005 |
Histiocytoid Sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes.
Topics: Acetaminophen; Administration, Oral; Adult; Aged; Biopsy, Needle; Cohort Studies; Diclofenac; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Histiocytes; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Male; Middle Aged; Prednisone; Severity of Illness Index; Sweet Syndrome; Treatment Outcome | 2005 |
Formulation of microemulsion systems for transdermal delivery of aceclofenac.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Diclofenac; Emulsions; Male; Particle Size; Rats; Rats, Sprague-Dawley; Skin Absorption; Solubility; Viscosity | 2005 |
Anaphylactic reaction after aceclofenac intake.
Topics: Aged; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Hypersensitivity; Humans; Male | 2006 |
Effect of processing variables on micro particulate system of aceclofenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cellulose; Delayed-Action Preparations; Diclofenac; Microscopy, Electron, Scanning; Microspheres; Rheology; Solubility | 2006 |
Generalized pustular psoriasis precipitated by aceclofenac.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Diclofenac; Humans; Male; Psoriasis; Suppuration | 2006 |
[A case of complete regression of hepatocellular carcinoma during administration of COX-2 inhibitor].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Female; Humans; Lactones; Liver Neoplasms; Pyrazoles; Sulfonamides; Sulfones | 2006 |
Topical delivery of aceclofenac from lecithin organogels: preformulation study.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Carriers; Drug Compounding; Gels; In Vitro Techniques; Membranes, Artificial; Oleic Acids; Phase Transition; Phosphatidylcholines; Rats; Skin Absorption; Solubility; Viscosity; Water | 2006 |
Allergic contact dermatitis due to aceclofenac.
Topics: Administration, Cutaneous; Aged; Anti-Inflammatory Agents, Non-Steroidal; Dermatitis, Allergic Contact; Diagnosis, Differential; Diclofenac; Humans; Male; Patch Tests; Stroke | 2006 |
In vitro effects of non-steroidal anti-inflammatory drugs on cytokine, prostanoid and matrix metalloproteinase production by interface membranes from loose hip or knee endoprostheses.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cytokines; Diclofenac; Dinoprostone; Female; Hip Prosthesis; Humans; Indomethacin; Knee Prosthesis; Matrix Metalloproteinases; Middle Aged; Piroxicam; Tissue Inhibitor of Metalloproteinases | 2007 |
High-performance liquid chromatography and pharmacokinetics of aceclofenac in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry Techniques, Analytical; Chromatography, High Pressure Liquid; Diclofenac; Ethylamines; Hydrogen-Ion Concentration; Ibuprofen; Methanol; Models, Chemical; Rats; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2007 |
Fixed drug eruption due to aceclofenac.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Diclofenac; Drug Eruptions; Female; Humans; Middle Aged; Neck; Patch Tests | 2007 |
Influence of amorphous cyclodextrin derivatives on aceclofenac release from directly compressible tablets.
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Crystallography, X-Ray; Cyclodextrins; Diclofenac; Excipients; Hardness; Microscopy, Electron, Scanning; Particle Size; Solubility; Spectroscopy, Fourier Transform Infrared; Tablets | 2007 |
Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies.
Topics: Alginates; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Calorimetry, Differential Scanning; Carrageenan; Chemistry, Pharmaceutical; Crystallization; Diclofenac; Drug Stability; Edema; Emulsions; Glucuronic Acid; Hexuronic Acids; In Vitro Techniques; Mice; Microscopy, Electron, Scanning; Microspheres; Pain Measurement; Particle Size; Povidone; Rats; Rats, Wistar; Solubility; Spectrophotometry, Infrared | 2007 |
Photodegradation and in vitro phototoxicity of aceclofenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cysteine; Dermatitis, Phototoxic; Diclofenac; Erythrocytes; Glutathione; Hemolysis; Humans; In Vitro Techniques; Linoleic Acid; Lipid Peroxidation; Luminescence; Oxidants; Oxidation-Reduction; Oxygen; Photolysis; Serum Albumin; Ultraviolet Rays | 2007 |
[After taking non-steroidal anti-inflammatory agents. What is the cause of the "blue spot?" ].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Diclofenac; Dose-Response Relationship, Drug; Drug Eruptions; Female; Humans; Tendinopathy | 2007 |
Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Calorimetry, Differential Scanning; Chitosan; Diclofenac; Male; Microscopy, Electron, Scanning; Particle Size; Rats; Rats, Wistar; Solubility; Solvents; X-Ray Diffraction | 2008 |
Simultaneous determination of aceclofenac and its three metabolites in plasma using liquid chromatography-tandem mass spectrometry.
Topics: Chromatography, Liquid; Diclofenac; Humans; Sensitivity and Specificity; Tandem Mass Spectrometry | 2008 |
Preventing peridural fibrosis with nonsteroidal anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cicatrix; Connective Tissue; Diclofenac; Disease Models, Animal; Dura Mater; Epidural Space; Fibroblasts; Fibrosis; Inflammation; Laminectomy; Lumbar Vertebrae; Postoperative Complications; Rabbits; Spinal Canal; Tissue Adhesions; Treatment Outcome | 2008 |
Nanoemulsions as vehicles for transdermal delivery of aceclofenac.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemistry, Pharmaceutical; Diclofenac; Diffusion Chambers, Culture; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Stability; Edema; Emulsions; Excipients; Kinetics; Male; Mice; Nanoparticles; Oils; Particle Size; Permeability; Rats; Rats, Wistar; Skin; Skin Absorption; Skin Irritancy Tests; Surface Properties; Technology, Pharmaceutical; Temperature; Viscosity; Water | 2007 |
Mathematical evaluation of similarity factor using various weighing approaches on aceclofenac marketed formulations by model-independent method.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Data Interpretation, Statistical; Diclofenac; Reproducibility of Results; Solubility; Tablets | 2008 |
Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Diclofenac; Diffusion; Drug Compounding; Drug Evaluation, Preclinical; Inflammation; Liposomes; Male; Materials Testing; Rats | 2008 |
Evaluation of SLS: APG mixed surfactant systems as carrier for solid dispersion.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Crystallography, X-Ray; Diclofenac; Dosage Forms; Drug Carriers; Drug Compounding; Ethanol; Glucosides; Kinetics; Micelles; Microscopy, Electron, Scanning; Models, Chemical; Sodium Dodecyl Sulfate; Solubility; Solvents; Spectroscopy, Fourier Transform Infrared; Surface Tension; Surface-Active Agents; Technology, Pharmaceutical | 2008 |
Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Stability; Humans; Male; Rats; Rats, Wistar; Solubility; Tablets; Technology, Pharmaceutical | 2008 |
Vesicular aceclofenac systems: a comparative study between liposomes and niosomes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Diclofenac; Drug Compounding; Drug Delivery Systems; Liposomes; Microscopy, Electron; Particle Size | 2008 |
Simultaneous determination of aceclofenac, paracetamol, and chlorzoxazone by RP-HPLC in pharmaceutical dosage form.
Topics: Acetaminophen; Chlorzoxazone; Chromatography, High Pressure Liquid; Diclofenac; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Skin permeation mechanism of aceclofenac using novel nanoemulsion formulation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Diclofenac; Emulsions; Nanoparticles; Rats; Rats, Wistar; Skin; Skin Absorption; Spectroscopy, Fourier Transform Infrared | 2008 |
Multiparticulate drug delivery system of aceclofenac: development and in vitro studies.
Topics: Acrylic Resins; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Diclofenac; Drug Delivery Systems; Drug Evaluation, Preclinical; Tablets, Enteric-Coated; Technology, Pharmaceutical | 2009 |
First evidence for occurrence of hydroxylated human metabolites of diclofenac and aceclofenac in wastewater using QqLIT-MS and QqTOF-MS.
Topics: Chromatography, High Pressure Liquid; Deuterium Exchange Measurement; Diclofenac; Humans; Hydroxylation; Mass Spectrometry; Molecular Structure; Waste Disposal, Fluid; Water Pollutants, Chemical | 2008 |
PARFLEX--a very useful drug for management of surgical pain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans; Inflammation; Male; Middle Aged; Pain, Postoperative | 2008 |
Simultaneous HPLC-UV determination of rhein and aceclofenac in human plasma.
Topics: Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Calibration; Chromatography, High Pressure Liquid; Diclofenac; Enzyme Inhibitors; Humans; Indicators and Reagents; Reproducibility of Results; Spectrophotometry, Ultraviolet | 2009 |
Almotriptan efficacy in migraine with allodynia: a critique of Schoenen et al.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Migraine Disorders; Multivariate Analysis; Physical Stimulation; Pilot Projects; Prevalence; Serotonin Receptor Agonists; Somatosensory Disorders; Treatment Outcome; Tryptamines | 2009 |
Aceclofenac organogels: in vitro and in vivo characterization.
Topics: Animals; Diclofenac; Gels; Lecithins; Light; Male; Rats; Scattering, Radiation; Skin; Solubility; Viscosity | 2009 |
Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.
Topics: Aluminum Compounds; Aluminum Silicates; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Diclofenac; Drug Carriers; Drug Stability; Excipients; Hydrogen Bonding; Magnesium; Magnesium Compounds; Silicates; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2009 |
Product development studies of amino acid conjugate of Aceclofenac.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Calorimetry, Differential Scanning; Chromatography, Thin Layer; Crystallography; Diclofenac; Female; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Male; Mass Spectrometry; Particle Size; Phenylalanine; Prodrugs; Rats; Rats, Inbred Strains; Solubility; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Stomach; Transition Temperature; X-Ray Diffraction | 2009 |
Preparation and characterization of spray-dried mucoadhesive microspheres of aceclofenac.
Topics: Acrylates; Acrylic Resins; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Diclofenac; Diffusion; Drug Carriers; Male; Microscopy, Electron, Scanning; Microspheres; Rats; Rats, Wistar | 2009 |
Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.
Topics: Chemistry, Pharmaceutical; Delayed-Action Preparations; Diclofenac; Hypromellose Derivatives; Methylcellulose; Solubility; Tablets; Verapamil; Water | 2009 |
Photoallergic contact dermatitis due to diclofenac with cross-reaction to aceclofenac: two case reports.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dermatitis, Photoallergic; Diclofenac; Female; Humans; Male; Middle Aged; Osteoarthritis; Patch Tests | 2009 |
Evaluation and modeling of the eutectic composition of various drug-polyethylene glycol solid dispersions.
Topics: Chlorpropamide; Crystallization; Diclofenac; Drug Carriers; Haloperidol; Loratadine; Models, Chemical; Phase Transition; Polyethylene Glycols; Spectroscopy, Fourier Transform Infrared; Transition Temperature | 2011 |
Development and characterization of enteric-coated immediate-release pellets of aceclofenac by extrusion/spheronization technique using kappa-carrageenan as a pelletizing agent.
Topics: Acrylic Resins; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Biological Availability; Carrageenan; Chemistry, Pharmaceutical; Diclofenac; Drug Implants; Excipients; Lactose; Particle Size; Pharmaceutical Preparations; Polymers; Povidone; Solubility | 2010 |
Hypertrophic cranial pachymeningitis induced by long-term administration of nonsteroidal antiinflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Brain; Diclofenac; Dura Mater; Headache; Humans; Indomethacin; Magnetic Resonance Imaging; Male; Meningitis; Tomography, X-Ray Computed; Young Adult | 2010 |
Design, synthesis, hydrolysis kinetics and phamacodynamic profiles of histidine and alanine conjugates of aceclofenac.
Topics: Alanine; Animals; Diclofenac; Drug Design; Histidine; Humans; Hydrolysis; Pain Measurement; Rats; Rats, Wistar | 2010 |
Evaluation of the microstructure of semicrystalline solid dispersions.
Topics: Calorimetry, Differential Scanning; Chlorpropamide; Diclofenac; Excipients; Haloperidol; Microscopy, Atomic Force; Pharmaceutical Preparations; Polyethylene Glycols; Scattering, Small Angle; Solubility; X-Ray Diffraction | 2010 |
Evaluation of extemporaneously manufactured topical gels containing aceclofenac on inflammation and hyperalgesia in rats.
Topics: Acrylic Resins; Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemistry, Pharmaceutical; Diclofenac; Disease Models, Animal; Edema; Female; Gels; Hyperalgesia; Inflammation; Male; Polyethylene Glycols; Rats; Rats, Wistar | 2010 |
Glycerogelatin-based ocular inserts of aceclofenac: physicochemical, drug release studies and efficacy against prostaglandin E₂-induced ocular inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Chemistry, Pharmaceutical; Cross-Linking Reagents; Delayed-Action Preparations; Diclofenac; Diffusion; Dinoprostone; Eye Diseases; Gelatin; Glycerol; Inflammation; Ophthalmic Solutions; Polymers; Rabbits; Vision, Ocular | 2011 |
Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug delivery.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Chitosan; Colon; Computer Simulation; Diclofenac; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Stability; Excipients; Glutaral; Male; Microspheres; Particle Size; Polymethacrylic Acids; Rats; Stomach | 2010 |
Preparation, in vitro and in vivo evaluation of algino-pectinate bioadhesive microspheres: An investigation of the effects of polymers using multiple comparison analysis.
Topics: Adhesiveness; Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Diclofenac; Disease Models, Animal; Drug Carriers; Edema; Glucuronic Acid; Hexuronic Acids; Inflammation; Male; Microspheres; Pectins; Rats; Rats, Wistar; Stomach | 2010 |
Aceclofenac topical dosage forms: in vitro and in vivo characterization.
Topics: Acrylic Resins; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Diclofenac; Edema; Gels; Hyperalgesia; Hypromellose Derivatives; Inflammation; Male; Methylcellulose; Ointments; Polyethylene Glycols; Rabbits; Rats; Rats, Wistar; Skin Irritancy Tests; Solubility | 2010 |
Drug-induced Sweet's syndrome by aceclofenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Glucocorticoids; Humans; Middle Aged; Prednisolone; Sweet Syndrome; Treatment Outcome | 2011 |
Mixed micelle formation with hydrophobic and hydrophilic Pluronic block copolymers: implications for controlled and targeted drug delivery.
Topics: Animals; Cattle; Diclofenac; Drug Carriers; Hydrophobic and Hydrophilic Interactions; Micelles; Microscopy, Electron, Transmission; Polymers; Serum Albumin, Bovine; Spectrometry, Fluorescence | 2011 |
Aceclofenac delivery by microencapsulation using LBL self-assembly for delayed release.
Topics: Animals; Biological Availability; Chitosan; Delayed-Action Preparations; Diclofenac; Drug Compounding; Feces; Hydrogen-Ion Concentration; Male; Microscopy, Electron, Scanning; Particle Size; Pectins; Polymethacrylic Acids; Rats; Rats, Inbred Strains; Static Electricity; Surface Properties | 2011 |
Development and characterization of zein-based microcarrier system for sustained delivery of aceclofenac sodium.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Delayed-Action Preparations; Diclofenac; Drug Carriers; Drug Delivery Systems; Fibroblasts; Microspheres; Zein | 2012 |
Rheological studies on solid lipid nanoparticle based carbopol gels of aceclofenac.
Topics: Acrylic Resins; Adhesiveness; Diclofenac; Diffusion; Gels; Lipids; Nanoparticles; Particle Size; Pharmaceutical Preparations; Polyvinyls; Rheology; Temperature | 2012 |
Content uniformity in granules for aceclofenac controlled release (CR) tablets determined using near-infrared spectroscopy and wide area illumination (WAI) Raman spectroscopy.
Topics: Delayed-Action Preparations; Diclofenac; Quality Control; Spectroscopy, Near-Infrared; Spectrum Analysis, Raman; Tablets | 2012 |
Effect of aceclofenac on pharmacokinetic of phenytoin.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Diclofenac; Drug Interactions; Male; Phenytoin; Rabbits | 2012 |
Preparation and in vitro in vivo evaluation of aceclofenac loaded alginate microspheres: an investigation of effects of polymer using multiple comparison analysis.
Topics: Adhesiveness; Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium Chloride; Carrageenan; Diclofenac; Drug Compounding; Drug Stability; Edema; Glucuronic Acid; Goats; Hexuronic Acids; Intestinal Mucosa; Kinetics; Male; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polymers; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared | 2012 |
Development and validation of packed column supercritical fluid chromatographic technique for quantification of chlorzoxazone, paracetamol and aceclofenac in their individual and combined dosage forms.
Topics: Acetaminophen; Carbon Dioxide; Chlorzoxazone; Chromatography, Supercritical Fluid; Diclofenac; Drug Combinations; Linear Models; Methanol; Pressure; Reproducibility of Results; Sensitivity and Specificity; Temperature | 2012 |
Formulation development and optimization of bilayer tablets of aceclofenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cellulose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diclofenac; Drug Delivery Systems; Lactose; Methylcellulose; Solubility; Tablets | 2012 |
Quantitative determination of aceclofenac and its three major metabolites in rat plasma by HPLC-MS/MS.
Topics: Animals; Anti-Inflammatory Agents; Chromatography, High Pressure Liquid; Diclofenac; Rats; Tandem Mass Spectrometry | 2012 |
Physicochemical principles of controlled release solid dispersion containing a poorly water-soluble drug.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diclofenac; Drug Carriers; Drug Compounding; Hydrogen Bonding; Hydrogen-Ion Concentration; Kinetics; Particle Size; Poloxamer; Polyethylene Glycols; Sodium Bicarbonate; Solubility; Solvents; Surface Properties; Technology, Pharmaceutical; Water | 2010 |
Effect of particle size on the dissolution behaviors of poorly water-soluble drugs.
Topics: Chemistry, Pharmaceutical; Crystallization; Diclofenac; Hydrochlorothiazide; Ibuprofen; Kinetics; Models, Chemical; Particle Size; Solubility; Solvents; Surface Properties; Technology, Pharmaceutical; Water | 2012 |
Electrospun zein/eudragit nanofibers based dual drug delivery system for the simultaneous delivery of aceclofenac and pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Carriers; Drug Combinations; Drug Compounding; Gastric Mucosa; Nanofibers; Pantoprazole; Polymethacrylic Acids; Proton Pump Inhibitors; Rats; Rats, Wistar; Zein | 2012 |
To evaluate efficacy and safety of fixed dose combination of aceclofenac + paracetamol + thiocolchicoside (acenac-MR) in the treatment of acute low back pain.
Topics: Acetaminophen; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Diclofenac; Drug Combinations; Female; Humans; Low Back Pain; Male; Middle Aged; Treatment Outcome; Young Adult | 2012 |
Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
Topics: Acrylic Resins; Administration, Ophthalmic; Animals; Arachidonic Acid; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Cornea; Diclofenac; Drug Delivery Systems; Drug Stability; Eye; Goats; Inflammation; Nanoparticles; Particle Size; Permeability; Polymers; Rabbits; Solutions; Spectroscopy, Fourier Transform Infrared; Static Electricity; Surface Properties; Suspensions; X-Ray Diffraction | 2013 |
Development and implication of methodology for aceclofenac in pure and pharmaceutical formulations by microwave assisted spectrophotometry.
Topics: Calibration; Chemistry, Pharmaceutical; Diclofenac; Linear Models; Microwaves; Molybdenum; Reference Standards; Reproducibility of Results; Spectroscopy, Fourier Transform Infrared; Sulfuric Acids; Tablets; Temperature; Time Factors | 2013 |
Topical delivery of aceclofenac as nanoemulsion comprising excipients having optimum emulsification capabilities: preparation, characterization and in vivo evaluation.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Diclofenac; Drug Delivery Systems; Emulsions; Excipients; Gels; Microscopy, Electron, Transmission; Oils; Permeability; Rats; Refractometry; Skin; Skin Absorption; Surface-Active Agents; Thermodynamics; Viscosity | 2013 |
Oil-entrapped sterculia gum-alginate buoyant systems of aceclofenac: development and in vitro evaluation.
Topics: Alginates; Diclofenac; Glucuronic Acid; Hexuronic Acids; Karaya Gum; Kinetics; Oils; Particle Size; Surface Properties | 2013 |
Aceclofenac-loaded chitosan-tamarind seed polysaccharide interpenetrating polymeric network microparticles.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Carrageenan; Chitosan; Diclofenac; Disease Models, Animal; Drug Delivery Systems; Edema; Glutaral; In Vitro Techniques; Male; Microspheres; Polymers; Polysaccharides; Rats; Rats, Sprague-Dawley; Seeds; Spectroscopy, Fourier Transform Infrared; Tamarindus | 2013 |
Formulation and biopharmaceutical evaluation of a transdermal patch containing aceclofenac.
Topics: Administration, Oral; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Diclofenac; Dose-Response Relationship, Drug; Drug Delivery Systems; Humans; In Vitro Techniques; Male; Middle Aged; Rats; Rats, Sprague-Dawley; Skin Absorption; Transdermal Patch | 2013 |
Aceclofenac-loaded unsaturated esterified alginate/gellan gum microspheres: in vitro and in vivo assessment.
Topics: Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Carrageenan; Delayed-Action Preparations; Diclofenac; Disease Models, Animal; Glucuronic Acid; Hexuronic Acids; Inflammation; Male; Microspheres; Polysaccharides, Bacterial; Rabbits; Rats; Rats, Sprague-Dawley | 2013 |
Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Arthritis, Rheumatoid; Calorimetry, Differential Scanning; Coated Materials, Biocompatible; Delayed-Action Preparations; Diclofenac; Drug Carriers; Drug Chronotherapy; Drug Compounding; Drug Stability; Gastric Juice; Intestinal Secretions; Male; Microspheres; Particle Size; Pectins; Polymethacrylic Acids; Rats; Rats, Wistar; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tissue Distribution | 2013 |
Inulin-based tablet in capsule device for variable multipulse delivery of aceclofenac: optimization and in vivo roentgenography.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Capsules; Chemistry, Pharmaceutical; Colon; Delayed-Action Preparations; Diclofenac; Diffusion; Drug Carriers; Fluoroscopy; Gastrointestinal Transit; Gelatin; Hydrogen-Ion Concentration; Intestinal Secretions; Intestines; Inulin; Kinetics; Models, Statistical; Polymethacrylic Acids; Rabbits; Reproducibility of Results; Solubility; Tablets, Enteric-Coated; Technology, Pharmaceutical | 2013 |
Effect of excipients on dissolution enhancement of aceclofenac solid dispersions studied using response surface methodology: a technical note.
Topics: Calorimetry, Differential Scanning; Diclofenac; Drug Carriers; Excipients; Microscopy, Electron, Scanning; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; X-Ray Diffraction | 2014 |
Aceclofenac-induced acute tubulointerstitial nephritis in a patient with diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Complications; Diabetes Mellitus; Diclofenac; Female; Humans; Nephritis, Interstitial | 2013 |
Enhanced solubility and modified release of poorly water-soluble drugs via self-assembled gelatin-oleic acid nanoparticles.
Topics: Benzimidazoles; Benzoates; Diclofenac; Gelatin; Nanoparticles; Oleic Acid; Particle Size; Powder Diffraction; Solubility; Spectroscopy, Fourier Transform Infrared; Telmisartan; Tetrazoles; Valine; Valsartan; Water; X-Ray Diffraction | 2013 |
Development of aceclofenac nanovesicular system using biomaterial for transdermal delivery: physical characterization, ex vivo, in vivo, and anti-inflammatory studies.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Biocompatible Materials; Ceramides; Diclofenac; Drug Carriers; Drug Stability; Humans; Membranes, Artificial; Nanostructures; Permeability; Physical Phenomena; Skin; Skin Absorption | 2013 |
Optimization of aceclofenac-loaded pectinate-poly(vinyl pyrrolidone) beads by response surface methodology.
Topics: Diclofenac; Drug Liberation; Microspheres; Pectins; Povidone | 2013 |
Carbopol gel containing chitosan-egg albumin nanoparticles for transdermal aceclofenac delivery.
Topics: Acrylic Resins; Administration, Cutaneous; Animals; Calorimetry, Differential Scanning; Chitosan; Diclofenac; Drug Delivery Systems; Gels; In Vitro Techniques; Mice; Nanoparticles; Ovalbumin; Particle Size; Permeability; Rats; Spectroscopy, Fourier Transform Infrared; Static Electricity; Viscosity; X-Ray Diffraction | 2014 |
Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Diclofenac; Drug Carriers; Drug Compounding; Drug Delivery Systems; Excipients; Gels; Lipids; Male; Nanoparticles; Particle Size; Poloxamer; Polysaccharides, Bacterial; Rats; Rats, Wistar; Skin; Skin Absorption; Swine | 2013 |
Validated stability-indicating assay method for simultaneous determination of aceclofenac and thiocolchicoside using RP-HPLC.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Colchicine; Diclofenac; Drug Combinations; Drug Stability; Indicators and Reagents; Limit of Detection; Reproducibility of Results; Tablets | 2014 |
Angina bullosa hemorrhagica-like lesions: a rare presentation of drug-induced thrombocytopenia.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Blister; Diclofenac; Drug Eruptions; Female; Humans; Male; Oral Hemorrhage; Rifampin; Thrombocytopenia | 2015 |
Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Diclofenac; Drug Carriers; Male; Particle Size; Porosity; Rats; Rats, Wistar; Silicon Dioxide; Solubility; Solvents; Spectroscopy, Fourier Transform Infrared; Tablets; Water; X-Ray Diffraction | 2014 |
Aceclofenac microspheres: quality by design approach.
Topics: Analysis of Variance; Chemistry, Pharmaceutical; Diclofenac; Microscopy, Electron, Scanning; Microspheres; Spectroscopy, Fourier Transform Infrared; Statistics as Topic; X-Ray Diffraction | 2014 |
In vitro aceclofenac release from IPN matrix tablets composed of chitosan-tamarind seed polysaccharide.
Topics: Chitosan; Delayed-Action Preparations; Diclofenac; Drug Carriers; Seeds; Tablets; Tamarindus | 2014 |
Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsules; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diclofenac; Drug Carriers; Drug Liberation; Edema; Excipients; Gelatin; Kinetics; Lipids; Models, Chemical; Rats; Solubility; Technology, Pharmaceutical | 2015 |
Zinc-aceclofenac complex: synthesis, hydrolysis study and antiinflammatory studies.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemistry, Pharmaceutical; Computer Simulation; Diclofenac; Edema; Female; Hydrolysis; Male; Rats; Rats, Wistar; Spectrum Analysis; Stomach Ulcer; Zinc | 2014 |
Studies of the molecular geometry, vibrational spectra, frontier molecular orbital, nonlinear optical and thermodynamics properties of aceclofenac by quantum chemical calculations.
Topics: Absorption; Diclofenac; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Nonlinear Dynamics; Optical Phenomena; Quantum Theory; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Static Electricity; Thermodynamics; Vibration | 2014 |
Optimization of aceclofenac solid dispersion using Box-Behnken design: in-vitro and in-vivo evaluation.
Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cellulose; Chemistry, Pharmaceutical; Diclofenac; Drug Stability; Edema; Hypromellose Derivatives; Male; Mice; Pain; Rats, Wistar; Solubility | 2014 |
Absolute bioavailability and metabolism of aceclofenac in rats.
Topics: Administration, Intravenous; Administration, Oral; Animals; Biological Availability; Diclofenac; Male; Rats | 2015 |
Label-free optical biosensor for detection and quantification of the non-steroidal anti-inflammatory drug diclofenac in milk without any sample pretreatment.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigen-Antibody Reactions; Biosensing Techniques; Buffers; Calibration; Cattle; Diclofenac; Food Contamination; Immunoassay; Microscopy, Interference; Milk; Optics and Photonics; Polymers; Reproducibility of Results; Silanes; Transducers | 2014 |
Formulation and evaluation of guggul lipid nanovesicles for transdermal delivery of aceclofenac.
Topics: Administration, Cutaneous; Commiphora; Diclofenac; Drug Carriers; Microscopy, Electron, Transmission; Plant Extracts; Plant Gums | 2014 |
Development of a particle-settling tolerant transmission Raman scheme for analysis of suspension samples.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Spectrum Analysis, Raman | 2014 |
Selective interactions of zein microspheres with different class of drugs: an in vitro and in silico analysis.
Topics: Amino Acid Sequence; Catalytic Domain; Chemistry, Pharmaceutical; Computer Simulation; Diclofenac; Drug Compounding; Ligands; Metformin; Microspheres; Models, Molecular; Particle Size; Pharmaceutical Preparations; Promethazine; Receptors, Drug; Zein | 2014 |
Aceclofenac-loaded chondroitin sulfate conjugated SLNs for effective management of osteoarthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chondroitin Sulfates; Delayed-Action Preparations; Diclofenac; Drug Carriers; Humans; Injections, Intra-Articular; Lipids; Male; Nanoparticles; Osteoarthritis; Particle Size; Rats; Rats, Wistar; Technology, Pharmaceutical | 2014 |
Metal ion-induced alginate-locust bean gum IPN microspheres for sustained oral delivery of aceclofenac.
Topics: Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents; Diclofenac; Drug Delivery Systems; Edema; Galactans; Glucuronic Acid; Hexuronic Acids; Ions; Mannans; Metals; Microscopy, Electron, Scanning; Microspheres; Particle Size; Plant Gums; Polymers; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared | 2015 |
Design, characterization and in-vitro evaluation of different cellulosic acrylic and methacrylic polymers loaded aceclofenac microspheres.
Topics: Acrylates; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Methacrylates; Microspheres; Polymers; Solubility; Spectroscopy, Fourier Transform Infrared | 2014 |
Locust bean gum in the development of sustained release mucoadhesive macromolecules of aceclofenac.
Topics: Adhesiveness; Alginates; Delayed-Action Preparations; Diclofenac; Drug Carriers; Galactans; Glucuronic Acid; Hexuronic Acids; Mannans; Plant Gums | 2014 |
Synthesis, hydrolysis kinetics and pharmacological evaluation of aceclofenac prodrugs.
Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Diclofenac; Disease Models, Animal; Drug Design; Drug Stability; Edema; Female; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Male; Mice; Pain; Prodrugs; Rats, Wistar; Risk Assessment; Solubility; Stomach Ulcer | 2015 |
Novel alginate hydrogel core-shell systems for combination delivery of ranitidine HCl and aceclofenac.
Topics: Alginates; Chemistry, Pharmaceutical; Diclofenac; Drug Delivery Systems; Drug Liberation; Glucuronic Acid; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Microspheres; Particle Size; Polymethacrylic Acids; Ranitidine; Spectroscopy, Fourier Transform Infrared; Viscosity | 2015 |
Nanomiemgel--a novel drug delivery system for topical application--in vitro and in vivo evaluation.
Topics: Administration, Cutaneous; Aminoquinolines; Animals; Capsaicin; Cell Proliferation; Diclofenac; Disease Models, Animal; Drug Delivery Systems; Drug Stability; Emulsions; Gels; Humans; Imiquimod; Immunohistochemistry; In Vitro Techniques; Inflammation; Keratinocytes; Micelles; Microdialysis; Microscopy, Atomic Force; Nanoparticles; Organ Size; Permeability; Psoriasis; Rats; Rheology; Skin Absorption; Spleen | 2014 |
Novel approach of aceclofenac fast dissolving tablet.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Carboxymethylcellulose Sodium; Chemistry, Pharmaceutical; Diclofenac; Excipients; Hardness; Kinetics; Povidone; Solubility; Spectroscopy, Fourier Transform Infrared; Starch; Tablets; Water | 2015 |
Chitosan cocrystals embedded alginate beads for enhancing the solubility and bioavailability of aceclofenac.
Topics: Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Chitosan; Crystallization; Diclofenac; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Glucuronic Acid; Hexuronic Acids; Inflammation; Male; Particle Size; Rats; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2015 |
Optimization of sustained release aceclofenac microspheres using response surface methodology.
Topics: Calorimetry, Differential Scanning; Delayed-Action Preparations; Diclofenac; Microscopy, Electron, Scanning; Microspheres; Models, Theoretical; Reproducibility of Results; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2015 |
Effect of in vitro transcorneal approach of aceclofenac eye drops through excised goat, sheep, and buffalo corneas.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Buffaloes; Cornea; Diclofenac; Goats; Hydrogen-Ion Concentration; Ophthalmic Solutions; Sheep | 2015 |
Formulation and Characterization of Aceclofenac -Aloe vera Transemulgel.
Topics: Aloe; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Diclofenac; Disease Models, Animal; Drug Stability; Edema; Gels; Hydrogen-Ion Concentration; Inflammation; Male; Rats; Rats, Wistar; Skin Absorption; Viscosity | 2015 |
Urate crystal degradation for treatment of gout: a nanoparticulate combination therapy approach.
Topics: Absorption, Physiological; Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chickens; Diclofenac; Drug Carriers; Drug Compounding; Drug Stability; Drug Therapy, Combination; Eggs; Goats; Gout; Gout Suppressants; In Vitro Techniques; Nanoparticles; Rabbits; Solubility; Synovial Fluid; Tissue Distribution; Urate Oxidase; Uric Acid | 2015 |
Boswellia gum resin/chitosan polymer composites: Controlled delivery vehicles for aceclofenac.
Topics: Boswellia; Chitosan; Delayed-Action Preparations; Diclofenac; Drug Carriers; Plant Gums; Resins, Plant | 2015 |
Enhanced skin delivery of aceclofenac via hydrogel-based solid lipid nanoparticles.
Topics: Administration, Topical; Animals; Diclofenac; Drug Carriers; Hydrogels; Lipids; Nanoparticles; Rats; Rats, Sprague-Dawley; Skin; Skin Absorption | 2016 |
A pH-triggered delayed-release chronotherapeutic drug delivery system of aceclofenac for effective management of early morning symptoms of rheumatoid arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Carrageenan; Diclofenac; Drug Delivery Systems; Female; Hydrogen-Ion Concentration; Male; Microspheres; Pregnancy; Rats; Rats, Wistar; Syndrome | 2015 |
Biocompatible microemulsions of a model NSAID for skin delivery: A decisive role of surfactants in skin penetration/irritation profiles and pharmacokinetic performance.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Calorimetry, Differential Scanning; Diclofenac; Emulsions; Female; Humans; Irritants; Male; Rats; Rats, Wistar; Skin Absorption; Solubility; Sucrose; Surface-Active Agents | 2015 |
Biocompatible Nanoemulsions for Improved Aceclofenac Skin Delivery: Formulation Approach Using Combined Mixture-Process Experimental Design.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Chemistry, Pharmaceutical; Diclofenac; Drug Delivery Systems; Drug Stability; Emulsions; Female; Humans; Irritants; Nanostructures; Particle Size; Pharmaceutical Vehicles; Polysorbates; Skin Absorption; Young Adult | 2016 |
Metabolism of aceclofenac in cattle to vulture-killing diclofenac.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Asia; Cattle; Conservation of Natural Resources; Diclofenac; Endangered Species; Falconiformes | 2016 |
Electrospun Polymeric Core-sheath Yarns as Drug Eluting Surgical Sutures.
Topics: Animals; Cell Line; Delayed-Action Preparations; Diclofenac; Fibroblasts; Lactic Acid; Mice; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sutures; Wound Healing | 2016 |
Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.
Topics: Administration, Cutaneous; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Diclofenac; Drug Carriers; Inflammation; Liposomes; Male; Mice; Pain; Phospholipids; Rats; Rats, Wistar; Skin; Skin Absorption | 2016 |
Development and evaluation of decorated aceclofenac nanocrystals.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Cell Survival; Diclofenac; Dose-Response Relationship, Drug; Drug Compounding; Drug Liberation; HCT116 Cells; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Microscopy, Electron, Scanning; Molecular Structure; Nanoparticles; Particle Size; Poloxamer; Polyethylene Glycols; Polysorbates; Solubility | 2016 |
Novel pure component contribution, mean centering of ratio spectra and factor based algorithms for simultaneous resolution and quantification of overlapped spectral signals: An application to recently co-formulated tablets of chlorzoxazone, aceclofenac an
Topics: Acetaminophen; Algorithms; Calibration; Chemistry, Pharmaceutical; Chlorzoxazone; Diclofenac; Least-Squares Analysis; Reference Standards; Regression Analysis; Reproducibility of Results; Solutions; Spectrum Analysis; Tablets | 2016 |
Screening of natural polysaccharides extracted from the fruits of Pithecellobium dulce as a pharmaceutical adjuvant.
Topics: Adjuvants, Pharmaceutic; Antioxidants; Biphenyl Compounds; Diclofenac; Drug Evaluation, Preclinical; Drug Liberation; Fabaceae; Free Radical Scavengers; Fruit; Gas Chromatography-Mass Spectrometry; Kinetics; Methylation; Molybdenum; Monosaccharides; Particle Size; Phosphoric Acids; Phytochemicals; Picrates; Polysaccharides; Solubility; Spectroscopy, Fourier Transform Infrared; Water | 2016 |
Preparation and In Vivo Pharmacokinetics of the Tongshu Suppository.
Topics: Animals; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Color; Diclofenac; Drug Liberation; Hardness; Rabbits; Rats; Suppositories; Technology, Pharmaceutical | 2016 |
Gelatin-carboxymethyl tamarind gum biocomposites: In vitro characterization & anti-inflammatory pharmacodynamics.
Topics: Animals; Anti-Inflammatory Agents; Calorimetry, Differential Scanning; Diclofenac; Disease Models, Animal; Drug Carriers; Drug Liberation; Edema; Female; Gelatin; Hydrogels; Male; Microscopy, Electron, Scanning; Polysaccharides; Rats; Spectroscopy, Fourier Transform Infrared; Tamarindus | 2016 |
Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
Topics: Acrylic Resins; Cellulose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diclofenac; Drug Liberation; Hypromellose Derivatives; Polymers; Solubility; Tablets; Water | 2016 |
Modeling of aceclofenac metabolism to major metabolites in healthy volunteers.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Healthy Volunteers; Humans; Male; Models, Biological; Young Adult | 2016 |
Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Topics: Administration, Cutaneous; Animals; Cells, Cultured; Delayed-Action Preparations; Diclofenac; Drug Carriers; Drug Liberation; Drug Stability; Emulsions; Female; Humans; Keratinocytes; Lipids; Mice; Nanostructures; Particle Size; Rheology; Skin Absorption | 2017 |
Acute effects of aceclofenac, COX-2 inhibitor, on penicillin-induced epileptiform activity.
Topics: Animals; Anticonvulsants; Cerebral Cortex; Cyclooxygenase 2 Inhibitors; Diclofenac; Epilepsy; Male; Penicillins; Rats, Wistar; Seizures | 2017 |
Polymer based microspheres of aceclofenac as sustained release parenterals for prolonged anti-inflammatory effect.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Diclofenac; Drug Carriers; Drug Liberation; Edema; Lactic Acid; Male; Microscopy, Electron, Scanning; Microspheres; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2017 |
An insight into the binding of aceclofenac with bovine serum albumin at physiological condition: a spectroscopic and computational approach.
Topics: Animals; Binding Sites; Cattle; Circular Dichroism; Computational Biology; Diclofenac; Protein Binding; Serum Albumin, Bovine; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 2018 |
Aceclofenac cocrystal nanoliposomes for rheumatoid arthritis with better dermatokinetic attributes: a preclinical study.
Topics: Animals; Arthritis, Rheumatoid; Delayed-Action Preparations; Diclofenac; Edema; Humans; Inflammation; Liposomes; Lysine; Mice; Nanoparticles; Rats; Skin; Xylenes | 2017 |
Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Diclofenac; Dogs; Drug Delivery Systems; Drug Liberation; Gastrointestinal Hemorrhage; Hydrogen-Ion Concentration; Hypromellose Derivatives; Intestinal Secretions; Male; Solubility; Tablets | 2017 |
Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Diclofenac; Female; Humans; Interleukin-1beta; Interleukin-6; Lipids; Matrix Metalloproteinase 1; MCF-7 Cells; Methotrexate; Mice; Mice, Inbred BALB C; Nanoparticles; Polymers; Tumor Necrosis Factor-alpha | 2017 |
Chitosan - Locust bean gum interpenetrating polymeric network nanocomposites for delivery of aceclofenac.
Topics: Chitosan; Delayed-Action Preparations; Diclofenac; Drug Carriers; Drug Liberation; Galactans; Mannans; Nanocomposites; Plant Gums | 2017 |
A Case of Acute Myocardial Infarction Induced by Selective Cyclooxygenase-2 Inhibitor.
Topics: Calcium Channel Blockers; Cyclooxygenase 2 Inhibitors; Diclofenac; Humans; Male; Middle Aged; Myocardial Infarction; Nitrates; Nitroglycerin; Orphenadrine | 2017 |
Aceclofenac oil drops: characterization and evaluation against ocular inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzyl Alcohol; Buffaloes; Chemistry, Pharmaceutical; Diclofenac; Female; Goats; Inflammation; Male; Ophthalmic Solutions; Permeability; Plant Oils; Rabbits; Sheep | 2018 |
Studies on Solubility Enhancement of Poorly Soluble NSAID Using Dual Approach of Micro-environmental pH Modulation and Melt Granulation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Diclofenac; Hydrogen-Ion Concentration; Solubility; Tablets; X-Ray Diffraction | 2017 |
Enhancement of ocular efficacy of aceclofenac using biodegradable PLGA nanoparticles: formulation and characterization.
Topics: Administration, Ophthalmic; Animals; Arachidonic Acid; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Diclofenac; Disease Models, Animal; Drug Liberation; Eye Diseases; Lactic Acid; Nanoparticles; Particle Size; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; X-Ray Diffraction | 2017 |
Novel drug delivery of dual acting prodrugs of hydroxychloroquine with aryl acetic acid NSAIDs: Design, kinetics and pharmacological study.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Arthritis, Rheumatoid; Carrageenan; Diclofenac; Drug Design; Female; Freund's Adjuvant; Hydroxychloroquine; Inflammation; Male; Mice; Prodrugs; Pyrroles; Rats; Rats, Wistar | 2017 |
Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Diclofenac; Dose-Response Relationship, Drug; Excipients; Male; Mice; Nanoparticles; Particle Size; Rabbits; Solubility; Toxicity Tests, Acute | 2017 |
Development & validation of reversed phase HPLC method for quantification of water insoluble API.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calibration; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Diclofenac; Reference Standards; Reproducibility of Results; Solubility; Solvents; Spectrophotometry, Ultraviolet; Water | 2017 |
Quality surveillance of immediate release aceclofenac tablets (100 mg) available in local market.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Commerce; Diclofenac; Drug Compounding; Drug Liberation; Hardness; Hydrogen-Ion Concentration; Kinetics; Pakistan; Quality Control; Solubility; Tablets; Technology, Pharmaceutical | 2017 |
Simultaneous Determination of Tizanidine, Nimesulide, Aceclofenac and Paracetamol in Tablets and Biological Fluids Using Micellar Liquid Chromatography.
Topics: Acetaminophen; Chromatography, Liquid; Clonidine; Diclofenac; Humans; Limit of Detection; Linear Models; Micelles; Reproducibility of Results; Sulfonamides; Tablets | 2018 |
Liquid chromatography-tandem MS/MS method for simultaneous quantification of paracetamol, chlorzoxazone and aceclofenac in human plasma: An application to a clinical pharmacokinetic study.
Topics: Acetaminophen; Chlorzoxazone; Chromatography, Liquid; Diclofenac; Humans; Limit of Detection; Linear Models; Male; Reproducibility of Results; Tandem Mass Spectrometry | 2018 |
Extraction and characterization of cashew tree (Anacardium occidentale) gum; use in aceclofenac dental pastes.
Topics: Anacardium; Dental Materials; Diclofenac; Drug Delivery Systems; Humans; Periodontitis; Plant Gums; Viscosity | 2018 |
Severe bone marrow suppression due to methotrexate toxicity following aceclofenac-induced acute kidney injury.
Topics: Acute Kidney Injury; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Marrow Cells; Bone Marrow Diseases; Diclofenac; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Methotrexate; Oral Ulcer | 2018 |
Design, characterization, and evaluation of aceclofenac-loaded Eudragit RS 100 nanoparticulate system for ocular delivery.
Topics: Acrylic Resins; Administration, Ophthalmic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Chemistry, Pharmaceutical; Crystallization; Diclofenac; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Stability; Eye Diseases; Inflammation; Nanoparticles; Neutrophils; Particle Size; Rabbits | 2019 |
Aceclofenac-Galactose Conjugate: Design, Synthesis, Characterization, and Pharmacological and Toxicological Evaluations.
Topics: Acute Pain; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Caco-2 Cells; Carrageenan; Diclofenac; Disease Models, Animal; Drug Carriers; Drug Compounding; Edema; Galactose; Gastric Mucosa; Humans; Hydrolysis; Intestinal Mucosa; Male; Mice; Permeability; Platelet Aggregation; Prodrugs; Solubility; Stomach Ulcer | 2018 |
Non-pigmenting Fixed Drug Eruption: An Unusual Adverse Reaction to Aceclofenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Eruptions; Female; Humans; Young Adult | 2018 |
Combined use of biocompatible nanoemulsions and solid microneedles to improve transport of a model NSAID across the skin: In vitro and in vivo studies.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport; Diclofenac; Drug Delivery Systems; Drug Liberation; Emulsions; Microinjections; Nanoparticles; Needles; Rats, Wistar; Skin; Skin Absorption; Sucrose; Swine | 2018 |
Simultaneous analysis of acetylcarnitine, proline, hydroxyproline, citrulline, and arginine as potential plasma biomarkers to evaluate NSAIDs-induced gastric injury by liquid chromatography-tandem mass spectrometry.
Topics: Acetylcarnitine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Biomarkers; Chromatography, Liquid; Citrulline; Diclofenac; Dogs; Gastrointestinal Diseases; Hydroxyproline; Limit of Detection; Male; Proline; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tandem Mass Spectrometry | 2019 |
Multimetal organic frameworks as drug carriers: aceclofenac as a drug candidate.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Buffers; Diclofenac; Drug Carriers; Drug Compounding; Drug Liberation; Hydrogen-Ion Concentration; Kinetics; Molecular Structure; Organometallic Compounds; Solubility; Technology, Pharmaceutical | 2019 |
Formulation development and in vitro evaluation of fast dispersible, taste masked aceclofenac compacted pellets.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Compounding; Drug Liberation; Excipients; Flavoring Agents; Humans; Kinetics; Models, Chemical; Solubility; Tablets; Taste; Taste Perception | 2019 |
Eutexia for enhanced dissolution rate and anti-inflammatory activity of nonsteroidal anti-inflammatory agents: Caffeine as a melting point modulator.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Carrageenan; Diclofenac; Drug Liberation; Edema; Flurbiprofen; Male; Meloxicam; Powder Diffraction; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Transition Temperature; X-Ray Diffraction | 2019 |
Novel spectrophotometric methods for the determination of Leflunomide and Diacerein in binary mixtures.
Topics: Anthraquinones; Calibration; Diclofenac; Drug Combinations; Drug Stability; Leflunomide; Limit of Detection; Powders; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry; Tablets | 2019 |
Topics: Acrylic Resins; Administration, Buccal; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Carriers; Drug Compounding; Drug Liberation; Edema; Male; Methacrylates; Particle Size; Polysaccharides, Bacterial; Rats, Sprague-Dawley; Viscosity | 2019 |
ANALGESIC EFFECT OF INTRAVENOUS ASCORBIC ACID VERSUS ACELCOFENAC POST-TRANSALVEOLAR EXTRACTION: A CASE-CONTROL STUDY.
Topics: Administration, Intravenous; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Diclofenac; Double-Blind Method; Edema; Humans; Molar, Third; Pain, Postoperative; Tooth Extraction; Tooth, Impacted | 2019 |
Aceclofenac fast dispersible tablet formulations: Effect of different concentration levels of Avicel PH102 on the compactional, mechanical and drug release characteristics.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Compressive Strength; Diclofenac; Drug Compounding; Hardness; Kinetics; Solubility; Stress, Mechanical; Tablets; Tensile Strength | 2020 |
[The chemoreactomic analysis of the central mechanisms of action of non-steroidal anti-inflammatory drugs].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Ketoprofen; Opiate Alkaloids; Pain; Piroxicam | 2020 |
Synchronous UPLC Resolution of Aceclofenac and Diacerin in Their Powdered Forms and Matrix Formulation: Stability Study.
Topics: Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Diclofenac; Drug Stability; Linear Models; Powders; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2020 |
Effect of lipid and edge activator concentration on development of aceclofenac-loaded transfersomes gel for transdermal application:
Topics: Administration, Cutaneous; Diclofenac; Drug Carriers; Lipids; Skin | 2020 |
[Assessment of the safety, tolerability and effectiveness of first Russian generic aceclofenac in patients with undifferentiated peripheral inflammatory arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Female; Humans; Male; Russia | 2020 |
Development and in vitro Evaluation of Gastro-protective Aceclofenac-loaded Self-emulsifying Drug Delivery System.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Caco-2 Cells; Cell Survival; Diclofenac; Drug Delivery Systems; Drug Liberation; Emulsions; Excipients; Humans; Male; Nanostructures; Polyethylene Glycols; Polysorbates; Protective Agents; Rats, Sprague-Dawley; Solubility; Surface-Active Agents | 2020 |
Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations.
Topics: Calorimetry, Differential Scanning; Crystallization; Cystine; Diclofenac; Powder Diffraction; Solubility; X-Ray Diffraction | 2021 |
Pharmacokinetics and bioequivalence assessment of optimized directly compressible Aceclofenac (100 mg) tablet formulation in healthy human subjects.
Topics: Adult; Analysis of Variance; Area Under Curve; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cross-Over Studies; Diclofenac; Healthy Volunteers; Humans; Male; Tablets; Therapeutic Equivalency | 2020 |
Formulation design and evaluation of aceclofenac nanogel for topical application.
Topics: Chemistry, Pharmaceutical; Diclofenac; Emulsions; Nanogels; Nanoparticles; Particle Size | 2020 |
Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability.
Topics: Administration, Oral; Animals; Biological Availability; Calorimetry, Differential Scanning; Diclofenac; Drug Liberation; Kinetics; Nanoparticles; Particle Size; Rabbits; Spectroscopy, Fourier Transform Infrared; Suspensions; Tablets; Time Factors; X-Ray Diffraction | 2020 |
Influence of TiO2 on Mucosal Permeation of Aceclofenac: Analysis of Crystal Strain and Dislocation Density.
Topics: Animals; Cornea; Diclofenac; Diffusion; Drug Liberation; Goats; Mucous Membrane; Permeability; Titanium | 2020 |
Novel Aceclofenac-l-Cystine and Aceclofenac-Urea Cocrystals with Enhanced Oral Bioavailability.
Topics: Animals; Biological Availability; Crystallization; Cystine; Diclofenac; Rats; Rats, Wistar; Solubility; Urea | 2021 |
Effect of Different Carriers on In Vitro and In Vivo Drug Release Behavior of Aceclofenac Proniosomes.
Topics: Animals; Biological Availability; Diclofenac; Drug Carriers; Drug Liberation; Liposomes; Rats | 2021 |
Beta-Alanine and Tris-(hydroxyl methyl) Aminomethane as Peak Modifiers in the Development of RP-HPLC Methods Using Aceclofenac and Haloperidol Hydrochloride as Exemplar Drugs.
Topics: beta-Alanine; Chromatography, High Pressure Liquid; Diclofenac; Haloperidol; Methylamines; Pharmaceutical Preparations; Reproducibility of Results | 2021 |
[The open observational study of aceclofenac and vinpocetine effectiveness and tolerability in treatment of patients with chronic cerebrovascular disease after COVID-19 (AQUA study)].
Topics: Aged; Cerebrovascular Disorders; COVID-19; COVID-19 Drug Treatment; Diclofenac; Female; Humans; Male; Middle Aged; Post-Acute COVID-19 Syndrome; Vinca Alkaloids | 2021 |
Aceclofenac-Loaded Microspheres Prepared by Vesicular Ionotropic Gelation to Minimize Drug-induced Gastric Ulcers in Rats.
Topics: Alginates; Animals; Capsules; Diclofenac; Male; Microspheres; Polymers; Rats; Rats, Wistar; Stomach Ulcer | 2022 |
Metabolism of aceclofenac to diclofenac in the domestic water buffalo Bubalus bubalis confirms it as a threat to Critically Endangered Gyps vultures in South Asia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Asia; Buffaloes; Cattle; Diclofenac; Falconiformes | 2022 |
Safety and effectiveness of 4-week therapy with aceclofenac controlled release once a day.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Diclofenac; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Tablets; Treatment Outcome | 2022 |
Development of a New Voltammetric Method for Aceclofenac Determination on Glassy Carbon Electrode Modified with Hierarchical Nanocomposite.
Topics: Diclofenac; Electrodes; Humans; Nanocomposites; Nanotubes, Carbon | 2022 |
White analytical chemistry-driven stability-indicating concomitant chromatographic estimation of thiocolchicoside and aceclofenac using response surface analysis and red, green, and blue model.
Topics: Chromatography, High Pressure Liquid; Colchicine; Diclofenac | 2023 |